Worm orthologues of cytokinesis-associated proteins CIT and ASPM regulate neuronal microtubule dynamics and polarity in C. elegans Authors: Sunanda Sharma, Keerthana Ponniah, Ishanee Bandyopadhyay, Devyani Vadawale, Sandhya P. Koushika, Anindya Ghosh-Roy, Pablo Wappner, Pablo Wappner, Pablo Wappner, Pablo Wappner Published: 2026 ABSTRACT The polarized architecture of neurons is intricately associated with the modulation of microtubule dynamics. Over the years, several microtubule-associated factors that regulate neuronal polarity have been identified. However, the precise details of how microtubule arrangement and stability are established in axons and dendrites are not clearly understood. To uncover the relevant factors involved in the biological pathways governing microtubule regulation in neurons, we conducted a suppressor screen using the neuronal ectopic extension phenotype caused by the loss of the kinesin-13 family microtubule depolymerizing protein KLP-7 in C. elegans. Interestingly, apart from eleven variants of α (mec-12) and β (mec-7) tubulins, we isolated a variant of cytokinesis-associated protein, W02B8.2/citk-1, the suggested kinase-less orthologue of mammalian citron-rho interacting kinase (CIT). Little is known about the role of CIT in microtubule regulation in post-mitotic neurons. In this study, we found that the kinase-less worm orthologues of CIT, citk-1 and citk-2, redundantly modulate microtubule stability in the axon-like anterior process and maintain the population of plus-end-out microtubules in the dendrite-like posterior process of the PLM mechanosensory neurons in a cell-autonomous manner. In the absence of citk-1 and citk-2, PLM neurons exhibit variable morphological defects, including neurite growth and synaptic branch defects. Moreover, we find that CITK-1/2 work in the same genetic pathway as ASPM-1 (the worm homolog of mammalian ASPM (abnormal spindle-like microcephaly-associated protein)) to modulate plus-end dynamics of microtubules in PLM neurons. Our findings suggest that the cytokinesis-associated CITK-1/2 and ASPM-1 have non-mitotic roles in regulation of microtubules in differentiated PLM neurons. Introduction The fundamental unit of the nervous system, a neuron, is a highly polarized cell. Its ability to transmit information unidirectionally over long distances in neural networks relies on its structural and functional compartmentalization into dendrites and axons, the information receiving and transmitting processes [1]. One of the most sought after questions in neurobiology is how this elaborate architecture is developed and maintained throughout the lifespan of an organism. Previous studies have demonstrated that the regulation of neuronal polarity is closely linked to the arrangement of microtubule polarity and dynamics within neuronal compartments [2–6]. Microtubules are tubular, hollow, heteropolymers of α-β tubulin dimers, arranged in a head-to-tail manner, rendering them an intrinsic polarity. [7,8]. The visibly dynamic end with a β-tubulin exposed is called the plus end, and the less dynamic end with an α-tubulin exposed is called the minus end [9]. In the vertebrate neuronal system, in vitro studies have shown that axons have a unipolar plus-end-out (plus-end-distal to cell body) microtubule arrangement, while dendrites have a mixed microtubule polarity [10,11]. In vivo studies in invertebrate neurons also show a plus-end out microtubule arrangement in axons. However, the dendritic compartment in invertebrates mostly shows minus-end out microtubule polarity, and sometimes mixed [2,12–14]. Although little is known about how this compartmentalized microtubule arrangement and dynamics are achieved in neurons, recent studies have found novel insights into the roles of microtubule retrograde flow and polarity reversal in defining dendritic microtubule polarity [15–17]. Over the years, several microtubule-associated factors, including microtubule nucleation factors (such as g-TURC), polymerization factors (for instance, tubulins, CRMP-2/UNC-33), microtubule anchoring proteins (TRIM46, UNC-44/Ankyrin-G), and regulators of microtubule-end dynamics (plus-end-binding proteins EBP-2/3, minus-end binding protein Patronin/CAMSAP1/2/3), have been identified as regulators of neuronal microtubule dynamics and arrangement [6,18–22]. The microtubule cross-linking and anchoring factors, such as TRIM46 and Ankyrin-G, organize the microtubules in parallel bundles with plus-end-out polarity in the axon initial segment [23–26]. The microtubule end-binding proteins function as microtubule-stabilizing factors in axons and dendrites [21,22,27,28]. While Kinesin-13 family microtubule depolymerizing factor KIF2A/KLP-7 is a gatekeeper of dendritic identity in mouse, fish, and C. elegans neurons [2,4,5,29,30,31]. In the absence of kinesin-13, microtubules are hyper-stabilized, leading to reorganization of dendritic microtubules in a plus-end-out orientation [2,14]. However, it’s not completely clear how the microtubules in the distal axon, which are farther away from the AIS (axon initial segment), remain bundled and optimally stabilized. Furthermore, our understanding of how microtubules retain a mixed polarity organization within dendritic compartments is fragmentary. The mechanosensory neurons of C. elegans are an excellent model to study the regulation of microtubule dynamics and polarity in neurons [32–34]. Several microtubule-regulating factors, as well as molecules regulating post-translational modifications of tubulins, have been identified and studied in the ALM and PLM mechanosensory neurons [35–42]. The PLM (posterior lateral microtubule) neuron is a well-characterized bipolar neuron that, under the guidance of Wnt signaling gradient, polarizes and extends its neurites in the antero-posterior axis [2,43–46]. Its anterior neurite exhibits plus-end out microtubule arrangement, similar to vertebrate axon, while the posterior short neurite displays a mixed microtubule polarity, similar to vertebrate dendrites [2]. Any perturbation in the microtubule dynamics lead to distinct morphological changes in these neurons [2,35]. For instance, loss of Kinesin-13 family microtubule depolymerizing factor KLP-7 results in hyper-stabilization of microtubules and hence, ectopic neurites sprouting from mechanosensory neurons of mutant animals, including overgrowth of PLM posterior process [2]. The ALM (anterior lateral microtubule) neurons, on the other hand, are largely unipolar; however, in klp-7(0) animals, ALM neurons develop a visibly striking posterior ectopic extension [2,29]. These ectopic growths can be suppressed by destabilizing microtubules [2,35]. We hypothesized that the klp-7(0) mutant phenotype, combined with the powerful genetic toolbox of C. elegans [47], could be a promising platform for designing a suppressor screen aimed at identifying key regulators of neuronal microtubule dynamics, which could enhance our understanding of how microtubule dynamics and polarity are regulated in neurons. In this study, we isolated twenty-six suppressor variants in a screen and mapped twelve of these to the loci of mechanosensory neuron-specific tubulins mec-12 (α-tubulin) and mec-7 (β-tubulin). Incidentally, we isolated a variant of W02B8.2/citk-1, the proposed kinase-less worm orthologue of mammalian citron-rho kinase-associated protein/CIT/MCPH17 (autosomal recessive primary microcephaly-17), that is typically associated with cytokinesis. Variants of CIT/MCPH-17 are also associated with MCPH (Primary autosomal recessive microcephaly), a neurodevelopmental disorder [48–50]. Mammalian Cit gene majorly encodes two isoforms: a long isoform CIT-K, which has an N-terminal kinase domain and is ubiquitously expressed in proliferating cells, and a short isoform, CIT-N, which lacks the N-terminal kinase domain and is expressed exclusively in the post-mitotic and differentiated cells of the central nervous system [51,52]. It has been shown that the longer isoform CITK orchestrates midbody maturation and organization of spindle microtubule arrays in dividing cells [53–56]. Furthermore, in-situ hybridization experiments, showed CITK expression in a specific neuronal population in the cortex and thalamus, suggesting a role in neuronal differentiation [57]. The neuronal cell lines studies suggest the involvement of CITK as well as CITN, the kinase-less isoform of CIT, in limiting neurite outgrowth [57–59]. Additionally, in-vitro cultures and in vivo knockdown studies show that CIT-N regulates dendritic spine density and maturation. Notably, CIT-N is shown to be localized with spine-associated Golgi compartments and post-synaptic densities in vitro [57,59–61]. However, the roles of CIT proteins in the regulation of microtubule dynamics in post-mitotic neurons have not been explored. The suggested worm ortholog lacks the N-terminal kinase domain and shares a closer structural similarity with the CIT-N isoform. Here, using live imaging of EBP-2::GFP reporter we show that citk-1, along with its paralog citk-2, limits the microtubule dynamics in the axon-like anterior process of PLM mechanosensory neurons. It also maintains the plus-end-out microtubule population in the dendrite-like posterior process in a cell-autonomous manner. Furthermore, loss of both citron kinase proteins results in morphological defects in these neurons. Additionally, cytokinesis-associated protein ASPM-1, an orthologue of mammalian ASPM (Abnormal Spindle-like Microcephaly-Associated Protein, MCPH5), is a known partner of CIT in microtubule regulation during cell division. We found that aspm-1(ts) mutant phenocopies the citk microtubule defects. Both CITK-1 and ASPM-1 co-localize with the plus-tip protein EBP-2, and act in the same pathway to maintain the growing plus tips in the PLM neurite. These findings suggest that cytokinesis-associated proteins citk-1/citk-2 and aspm-1 have a post-differentiation role in the regulation of microtubule dynamics in neurons. Results A modifier screen using the ectopic extension phenotype of klp-7(0) identifies neuronal microtubule regulators, including tubulin variants Previous studies have shown that loss of KLP-7, a kinesin-13 family microtubule depolymerizing protein, leads to ectopic neurite extensions in mechanosensory neurons of C. elegans [2,29]. Most notably, the ALM mechanosensory neurons exhibit a striking posterior extension (Fig 1A and 1B’). In wild-type animals, the two bilateral ALM neurons are typically unipolar with a long anterior process; any posterior process is usually shorter than twice the length of the ALM cell body (Fig 1A and 1B’) [32]. However, in klp-7(0) mutant animals, this posterior process overgrows and may even extend beyond the cell body of the posteriorly situated PVM mechanosensory neuron (Fig 1A and 1B’) [2,29]. Furthermore, this phenotype can be suppressed by destabilization of microtubules, either by colchicine treatment or by a second-site mutation in mechanosensory neuron-specific tubulins, mec-7(β-tubulin), or mec-12 (α-tubulin) [2,14,35]. Isolation and mapping of suppressors of klp-7(0) ALM ectopic extension phenotype. (A) Schematics illustrates the hypothesis of EMS genetic screening. The wild-type animals with a steady-state microtubule dynamics exhibit no posterior extension from ALM mechanosensory neuron. Loss of function mutations in the microtubule depolymerizing protein KLP-7 (orange structure) leads to a posterior ectopic extension (drawn in purple) from the ALM cell body, associated with stable microtubules in these animals. The stable microtubules in the klp-7(0) mutant can be destabilized by EMS-induced second-site mutations in other microtubule regulators. The klp-7(0) ectopic extension phenotype would be reduced or absent in these suppressor mutant backgrounds. The blue and gray spheres represent α and β tubulins, respectively, which form the structure of microtubules. The purple ovals represent minus-end binding protein and the green hourglass like-structures represents plus-end binding proteins. The deep sky-blue hexagon depicts a probable microtubule stabilizing protein being mutated in suppressor mutant. Microtubule dynamics scheme is adapted from [62]. (B-B’) Representative confocal images and schematics of ALM and PLM neurons in the L4 staged wild-type, klp-7(0) mutant, a suppressor klp-7(0); mec-7(shr20) and a klp-7(0); mec-7(shr20); mec-7 (genomic DNA)[+] animals. The anterior end of animal is placed left, and vulva is positioned downwards in this and following figures. The ALM and PLM mechanosensory neurons of these animals express GFP (green fluorescent protein) under mechanosensory neuron specific promoter, pmec-7 (pmec-7::GFP, muIs32). (0) represents the loss of function deletion allele (tm2143) of klp-7. The white arrowhead labels the no ectopic extension phenotype in wild-type animal. The yellow and pink arrowheads point to strong and mild posterior extensions from ALM in klp-7(0) animals that ends either before or after the vulval position landmark(*), respectively. The red arrowhead points to suppression of ALM ectopic extension phenotype in klp-7(0); mec-7(shr20) mutant which is rescued (yellow arrowheads) in klp-7(0); mec-7(shr20); shrEx396(mec-7(gDNA)[+]) animals. A double-headed white arrow is drawn along the length of the PLM posterior process. (C) Quantification of the percentage of ALM neurons with ectopic extension in the klp-7(0) and the suppressor backgrounds klp-7(0); shr#, where shr# is the allele number. N = 3–4 independent replicates, n (number of neurons) = 45-55. (D) A schematic representation of the fosmid WRM062bA08, which includes the complete genomic cassette of the mec-7 gene, as shown. (E) Quantification of the percentage of ALM neurons with ectopic extension in the wild-type, klp-7(0), klp-7(0); mec-7(shr15), klp-7(0); mec-7(shr20), klp-7(0); mec-7(shr25), klp-7(0); mec-7(shr15); mec-7(gDNA) [+], klp-7(0); mec-7(shr20); mec-7(gDNA) [+] and klp-7(0); mec-7(shr25); mec-7(gDNA) [+] backgrounds, where g stands for genomic and mec-7(gDNA) is the fosmid WRM062bA08. N = 3–5 independent replicates, n (number of neurons) = 45-50. For C and E, ***, P < 0.001; **, P < 0.01, P values from 2x2 Fisher’s exact test comparing number of animals with No extension phenotype and number of animals with a Neurite defect (mild-extension + strong extension) between compared genotypes. This suggests that the klp-7(0) ectopic extension can serve as a platform to isolate novel microtubule regulators, enhancing our understanding of neuronal microtubule regulation (Fig 1A). Hence, we conducted an EMS mutagenesis screen and isolated twenty-six unique suppressor variants from 12,422 F1s (Fig 1A–1C). We classified the ALM ectopic extension into three categories based on their length: No extension (WT-like posterior extension), Mild extension (extension does not reach the vulva), or Strong extension (extension reaches or crosses the vulva) (Fig 1B–1B’). We then categorized the isolated suppressor variant as either a complete suppressor (no strong extensions in the population, e.g., shr10, shr15) or a mild suppressor (e.g., shr11, shr1) (Fig 1C). We used EMS density deep sequencing mapping to identify the molecular nature of these variants (please see the methods section for details). We mapped eleven variants to mechanosensory neuron-specific tubulins. The shr15, shr20, and shr25 suppressors mapped to mec-7 (β-tubulin) (Figs 1D, S1A and S1C), and shr1, shr9, shr10, shr14, shr17, shr19, shr21, and shr22 mapped to mec-12 (α-tubulin) (S1B and S1D Fig). We validated these results by expressing a wild-type copy of the gene of interest (mec-7 in this case) in the suppressor backgrounds, which successfully restored the klp-7(0) phenotype (Fig 1D and 1E). In summary, we isolated twenty-six unique suppressors of klp-7(0) ectopic extension phenotype. Eleven suppressor mutants mapped to mechanosensory neuron-specific tubulins mec-7 and mec-12. Since the loss of mec-7 and mec-12 is known to destabilize microtubules [2,14,35]. This finding validates our screen as a robust method for identifying neuronal microtubule regulators. Beyond these expected factors, we also identified some interesting candidates, including an RNA-binding protein, mbl-1 [14], and a cytokinesis-associated factor, citk-1, which we will be discussing in detail in the following sections. Mutations in a previously uncharacterized protein W02B8.2/citk-1 suppress the ectopic extension phenotype of klp-7(0) mutant We mapped the partial suppressor shr11 to a proline to leucine substitution at the 855th amino acid of the W02B8.2 locus on Chromosome II (Figs 2A, 2B and S2A). W02B8.2 is a proposed ortholog of mammalian citron-rho interacting kinase, a protein known for its role in midbody organization during cytokinesis [66]. Identification and characterization of CITK-1 and CITK-2 as partial suppressors of klp-7(0) phenotype. (A-A’) Representative confocal images of the ALM and PLM mechanosensory neurons in the L4 stage klp-7(0), citk-1(shr11); klp-7(0), citk-1(shr11); klp-7(0); shrEx432(pmec-4::citk-1[+]) and citk-2(ok2885); klp-7(0) mutant animals along with their respective schematics. These neurons are labeled green by pmec-7::GFP reporter. The yellow-arrowheads point to the strong ectopic extension from the ALM neuron that crosses the vulval landmark, labeled by an asterisk (*) in klp-7(0) animals and the citk-1(0); klp-7(0) animals with an extrachromosomal expression of pmec-4::citk-1. pmec-4 is a mechanosensory neuron specific promoter. The pink arrowheads point to the mild ectopic extension in citk-1(shr11); klp-7(0) and citk-2(ok2885); klp-7(0). The double-headed white arrow extends along the length of PLM posterior process. (B) The schematic of the exon and intron of the W02B8.2/citk-1 gene and the genomic positions of the identified candidate mutation within the citk-1 locus of the shr11 suppressor. At the bottom is a representation of the fosmid WRM062dD08 which contains the complete genomic cassette of the citk-1 gene. (C) The schematics of the two isoforms of mammalian citron-rho interacting kinase proteins and the C. elegans paralogs CITK-1 and CITK-2. Adapted from [63–65]. (D-E) Quantification of the absolute length of ALM ectopic extension (D) in the klp-7(0), citk-1(shr11); klp-7(0), citk-1(ok2328); klp-7(0), citk-1(shr11); klp-7(0); citk-1 genomic DNA [+], citk-1(shr11); klp-7(0); citk-1 cDNA [+] backgrounds and (E) in klp-7(0) and citk-2(ok2885); klp-7(0) backgrounds, where genomic citk-1 is the citk-1 fosmid WRM062dD08 and the citk-1(cDNA) is expressed under promoter pmec-4. For D, N = 3 independent replicates, n (number of neurons) = 30-50. For E, n = 38-44, N = 3. For D-E, Error bars represent SEM (Standard error mean), ***, P < 0.001; **, P < 0.01 and *, P < 0.05, for (D) P values from Kruskal Wallis test followed by Dunn’s multiple comparisons. For (E) P values from unpaired two tailed T test. We validated that shr11 is an allele of W02B8.2 through several validation experiments. First, an extrachromosomal expression of the wild-type W02B8.2 gene using fosmid WRM062dD08 (which has a complete genomic cassette of W02B8.2) (Fig 2B) restored the klp-7(0) phenotype (Figs 2A–2A’, 2D and S2B). Second, we found that a known deletion allele of W02B8.2, ok2328 (S2I Fig), reproduced the partial suppression of the klp-7(0) phenotype (Fig 2D). Finally, using a touch-neuron-specific promoter, pmec-4, we demonstrated that touch neuron-specific expression of W02B8.2 cDNA rescues the klp-7(0) phenotype (Figs 2A–2A’, 2D and S2B). This implies a cell-autonomous role of W02B8.2 in suppression of the klp-7(0) phenotype. We also validated that this transgenic expression of W02B8.2 does not cause any morphological defects in ALM mechanosensory neurons of wild-type animals (S2K Fig). This confirmed that the observed ALM ectopic extension in suppressor mutant on transgenic expression of W02B8.2 is indeed klp-7(0) phenotype rescue. The sequence and structural blast analysis suggest that W02B8.2 is a kinase-less orthologue of neuronal isoform of mammalian citron-rho-interacting kinase (CIT-N) (S2E Fig). We identified a second paralog in worms, F59A6.5, which shares 66% sequence homology with W02B8.2 (S2E and S2F Fig). Using the protein databases [63–65], we identified that W02B8.2 and F59A6.5 share structural homology with CIT-N [67] (Fig 2C). W02B8.2 and F59A6.5, like CIT-N, lack an N-terminal kinase domain but contain conserved regulatory regions. This includes an extended coiled-coil domain, a phorbol ester/DAG type Zn finger domain (C1 domain), a pleckstrin homology (PH) domain, and a Citron-Nik-1 homology (CNH) domain (Figs 2C, S2G and S2H). Based on these structural similarities, we named these loci citk-1 and citk-2, respectively. The identification of a paralog F59A6.5/citk-2 and observed partial suppression of klp-7(0) phenotype by W02B8.2/citk-1 mutations suggest a functional redundancy. Therefore, we assessed whether the citk-2 mutation phenocopies the suppression phenotype of citk-1(0) in the klp-7(0). We used a frameshift deletion variant of citk-2, ok2885, to evaluate the suppression (S2J Fig). The loss of citk-2 in the klp-7(0) background significantly reduced the length of ALM ectopic extension (Fig 2A–2A’ and 2E), suggesting that citk-2(ok2885) is also a partial suppressor of klp-7(0) phenotype. As previously reported, klp-7(0) mutant animals also display an overgrowth of the posterior process of PLM neurons [2] (Fig 2A–2A’). These mechanosensory neurons run ventrolaterally in the posterior half of the worm. Unlike ALM neurons, PLM neurons are bipolar with a long axon-like anterior process and a short dendrite-like posterior process extending into the tail of the animal (Fig 2A–2A’). We observed that mutations in either citk-1 or citk-2 in the klp-7(0) background can significantly suppress the overgrowth of the PLM posterior process (Figs 2A–2A’, S2C and S2D). Furthermore, the PLM overgrowth was rescued by an extrachromosomal expression of either a genomic or cDNA copy of wild-type citk-1 in the suppressor background (Figs 2A–2A’ and S2C). In conclusion, citk-1 and citk-2 are suggested kinase-less orthologs of the neuronal isoform of mammalian CIT. Additionally, mutations in citk-1 and citk-2 can partially suppress the microtubule-dynamics-associated neuronal ectopic extension phenotypes of klp-7(0) mutant. CITK proteins regulate dynamic microtubules in the anterior process of PLM neurons and microtubule arrangement in the posterior process of PLM neurons Building on our previous observations, we investigated the effects of loss of citk-1 and citk-2 on microtubule dynamics in the PLM mechanosensory neurons. We live-imaged microtubule plus-end dynamics using the established EBP-2::GFP reporter (plus-end binding protein) [2,68,29]. To quantify the dynamics of microtubules, we generated kymographs from time-lapse live images spanning 30 µm regions of interest in the anterior and posterior processes of PLM neurons (Fig 3A and 3C). CITK-1 and CITK-2 synergistically regulate microtubule dynamics in PLM neurons. (A, C) Schematic representation of the PLM neuron and representative kymographs and schematics of the EBP-2::GFP dynamics obtained from the anterior (A) and posterior (C) processes of PLM neurons in the wild-type, citk-1(0) (white background) (acquired using ANDOR camera on a Nikon Ti2 fluorescence system), and RNAi strain (in gray background) citk-1(0); lin-15b (-); shrsI2(pmec-3-sid-1 + unc-119[+]) fed on control and citk-2 RNAi bacteria (acquired on a Zeiss spinning disc confocal microscope). All these strains express pmec-4::EBP-2::GFP (juIs338) reporter. (The blue and orange dotted rectangles mark the 30um region of interest (ROI) in the (A) anterior (in blue) and (B) posterior process (in orange) of PLM neuron. These Rois are used to generate kymographs. One of the tracks from WT and citk-1(0) kymographs is enlarged in (A) to show its slope (ratio of growth length(x) and growth duration(y)) the direction of growth. The transgene pmec-3-sid-1 is used to overexpress sid-1 and enhance RNAi sensitivity in tissues expressing pmec-3, which includes PLM mechanosensory neurons. In the schematics, green and purple traces represent movements of EBP-2 bound microtubules away from the cell body (Plus end out) and movements towards the cell body (Minus end out), respectively. (B, D) Quantification of the number of observed diagonal tracks of EBP::GFP/growing microtubules in PLM anterior process (B) and fraction of minus-end-out microtubules (the number of ‘minus-end out’ microtubules/Total number of microtubules) in the posterior process of PLM neurons in different backgrounds. N = 3–4 independent replicates, n (number of neurons) = 14-63. The shrEx512(pmec-4::citk-1(cDNA)[+]) is a transgene of citk-1(cDNA) expressed under pmec-4. N = 3 independent replicates, n (number of neurons) = 8-22. For C-D Error bars represent SEM (Standard error mean), ***, P < 0.001; **, P < 0.01, *, P < 0.05, ns, not significant. The groups separated by dotted lines were analyzed independent of each other. For (B) strains left of dotted line, P values from ANOVA with Tukey’s multiple comparison test and for strains right of dotted line P values from Kruskal Wallis test followed by Dunn’s multiple comparisons. For (D) P values from Brown Forsythe and Welch ANOVA followed by Dunn’s multiple comparisons test. We observed that in comparison to wild-type animals, both citk-1(0) and citk-2(0) mutant animals display an increase in the number of growing microtubules/EBP-2::GFP comets in the PLM anterior process (Fig 3A and 3B). Moreover, the growth length and growth duration of these microtubule growth events significantly reduced (Figs 3A, S3A and S3B). This suggested an increase in the plus-end microtubule dynamics in the PLM anterior process. In contrast, the posterior process did not show a significant change in the number of growing comets (Figs 3C and S3D). Furthermore, the arrangement of microtubules in the anterior and posterior processes of PLM neurons is well defined [2,29]. The anterior process typically exhibits a plus-end-out microtubule polarity, similar to vertebrate axons. The kymographs from this region display a majority of diagonal tracks directed away from the cell body (plus-end-out, green trace) (Figs 3A and S3C). In contrast, the posterior process is known to display a mixed microtubule polarity, similar to the vertebrate dendrites [2]. Hence, kymographs exhibit a comparable fraction of comets directed away from (plus-end-out, green trace) and towards the cell body (minus-end-out, purple trace) (Fig 3C and 3D). We observed that the mutations in neither citk-1(0) nor citk-2(0) perturb the plus-end-out microtubule polarity in the anterior process of PLM neurons (Figs 3A and S3C). However, both citk-1 and citk-2 mutant animals displayed an increase in the fraction of minus-end-out microtubules in the PLM posterior process, suggesting a shift towards predominantly minus-end-out polarity (Fig 3C and 3D). The similar mutant phenotypes and molecular homology between citk-1 and citk-2 suggested a functional redundancy. To investigate the impact of losing both CITK-1 and CITK-2, we initially attempted to generate citk-1(0); citk-2(0) double homozygotes. However, the double homozygotes are not viable. This lethality is consistent with previous reports showing that simultaneous knockdown of both orthologues leads to gonadal sterility and embryonic lethality [66,69]. Consequently, we employed a neuron-specific knockdown strategy by feeding citk-2 RNAi to citk-1(ok2328) mutants in a strain with enhanced RNAi sensitivity in mechanosensory neurons [70–74]. We found that single knockdowns in the RNAi control strain mirrored the defects seen in single mutant animals (Figs 3A–3D and S3A–S3D). These defects were significantly aggravated by the knockdown of citk-2 in the citk-1 mutant background. In the PLM anterior process, the number of growing microtubules is significantly higher than in the single mutants (Fig 3A and 3C), and we observed an additive decrease in growth length and growth duration (Figs 3A, S3A and S3B). Furthermore, the posterior process of PLM neurons exhibited a significantly higher fraction of minus-end-out comets compared to single mutants, while the plus-end-out microtubule polarity of the anterior process remained unaffected (Figs 3A, 3C, 3D and S3C). These synergistic increases in microtubule dynamics confirm that CITK-1 and CITK-2 act redundantly to maintain neuronal microtubule polarity and stability. We validated the cell-autonomous role of citk-1 by expressing wild-type citk-1(cDNA) under the touch receptor neuron-specific promoter (pmec-4) in the citk-1(0) mutant animals. In these rescued animals, the number of growing microtubules in the PLM anterior process was comparable to wild-type animals, significantly less than the mutant animals (Fig 3B). Conversely, we observed an increase in both growth length and growth duration (S3A and S3B Fig). Moreover, the rescued neurons also restored mixed microtubule polarity, reversing the trend towards minus-end-out MT polarity in the mutant animals (Fig 3D). These findings demonstrate that mechanosensory neuron-specific expression of citk-1 is sufficient to rescue the microtubule defects, confirming that CITK-1 functions cell-autonomously to regulate neuronal microtubule stability and polarity. To further explore how citk-1 regulates microtubule dynamics in PLM neurons, we overexpressed citk-1 cDNA in mechanosensory neurons of wild-type animals. This resulted in an increased growth length and reduced growth duration of microtubules in the PLM anterior process without altering microtubule number or polarity (Figs 3B and S3A–S3C). This suggests that elevated levels of CITK-1 promote more rapid, sustained growth of existing polymerizing microtubules. Notably, the posterior process showed an increased fraction of minus-end-out microtubules upon overexpression (Fig 3D). This indicates that citk-1 might regulate microtubule polarity in the PLM posterior process in a dosage-dependent manner, further supporting its role as a key regulator of MT polarity in the PLM posterior process. We next investigated whether CITK-1 also influences the minus ends of microtubules in PLM neurons. Using the fluorescently tagged minus-end binding protein PTRN-1 (worm homolog of CAMSAP) [75,76], we quantified the number of ptrn-1::GFP puncta in PLM neurons of wild-type and citk-1(0) mutant animals (S3E Fig). We observed no significant change in anterior or posterior process of PLM neurons (S3E and S3F Fig). This suggests that CITK-1 neither regulates localization nor maintenance of this minus end marker in PLM mechanosensory neurons. Mammalian CIT-N mediated actin modulation has been implicated in regulating dendritic morphogenesis and neurite extension [59,61]. Therefore, we analyzed the actin dynamics in anterior process of PLM neurons in citk-1(0) animals using a previously established GFP::UtCH reporter (Actin binding protein Utrophin) [77–79]. However, we did not observe any significant change in actin dynamics in PLM neurons of mutant animals (S3G and S3H Fig). This suggests worm citk-1 is not involved in the modulation of actin dynamics in neurons. Taken together, these observations indicate that citk-1 and citk-2 redundantly limit the microtubule plus-end dynamics in the PLM anterior process. Furthermore, they maintain the plus-end-out population of microtubules in the posterior process of PLM neurons, thereby ensuring the mixed microtubule polarity characteristic of this dendrite-like compartment. PLM mechanosensory neurons displayed various morphological defects on loss of both citk-1 and citk-2 As previously described, perturbations in microtubule dynamics are associated with changes in the structure and function of these neurons, such as ectopic neurite growth observed in the klp-7(0) animals [2,14,29]. Therefore, to investigate whether the microtubule defects in citk-1 and citk-2 mutant animals translate to morphological changes, we analyzed PLM mechanosensory neurons in larval stage 4 animals. In wild-type animals, the PLM anterior process extends ventrolaterally towards the midbody past the vulva landmark (marked by an asterisk, in Figs 4A and S4A–S4A’). A short posterior process extends into the tail (Figs 4A and S4A–S4A’). While we observed no significant overall alterations in PLM morphology in citk-1 or citk-2 single mutants, specific growth defects were evident in the posterior process (S4A and S4B Fig). Both the loss-of-function allele citk-1(ok2328) and the missense allele, citk-1(shr11), displayed a significantly shorter PLM posterior process compared to the wild-type animals, which can be rescued by extrachromosomal expression of the WT citk-1 gene (S4A and S4B Fig). However, the length of the PLM anterior process in citk-1 mutants was similar to the wild-type animals (S4C Fig). Furthermore, the ventral synaptic branch, which forms a little posterior to the vulva in wild-type animals (marked by a white arrow in Figs 4A and S4A), was misplaced or duplicated in 11% of citk-1(ok2328), 7% of citk-1(shr11), and 6% of citk-2(ok2885) mutant animals (S4D Fig). Growth and guidance defects observed on knockdown of citk-2 in citk-1(0) animals. (A) Representative confocal images and schematics of ALM and PLM mechanosensory neurons of L4-stage WT animals fed on empty vector(control) and citk-1(ok2328) mutant animals fed on control citk-2 dsRNA. Both animals have an RNAi sensitive background lin-15b(-); shrsI2(pmec-3-sid-1 + unc-119[+]). The head of the worm (anterior end) is placed towards left, the tail (posterior end) points to the right, the dorsal edge of its body faces upward and the ventral edge with vulva faces downwards in the images. The confocal image is split into DIC channel image (top panel) and fluorescent image (lower panel) image. The mechanosensory neurons in these animals are labeled by a pmec-4::mCherry (tbIs222) reporter. Inset-1 zooms in on the distal end (marked by a blue dotted arrow) of anterior process of PLM neuron and the location of ALM cell body. Inset-2 focuses on the extent of PLM posterior process (marked by a double-headed pink arrow). The yellow arrow points to the ventral synaptic branch and the white arrowhead marks the ectopic branch. Vulva is marked by an asterisk (*), anus is marked by a generic symbol (¤) and the celeste-blue arrowhead points to the nerve ring. (B) Quantification of the normalized length of PLM posterior process in the wild-type control and citk-1(0) RNAi sensitive background animals fed on bacteria expressing either empty vector (control) or citk-1 or citk-2 ds RNA for RNAi mediated knockdown. (C) Plot of percentage of PLM neurons exhibiting anterior neurite growth defects such as overgrowth of PLM neuron (marked in light brown in inset-1 (A)). (D) Quantification of percentage of PLM neurons displaying a ventral synaptic branch defect, which in wild-type animals is localized a little posterior to vulva (labeled by yellow arrow in (A)). In mutant animals it can be mispositioned or duplicated or completely absent. B-D, N = 3 independent replicates, n (number of neurons) = 14-96. For B-D, ***, P < 0.001; **, P < 0.01, *, P < 0.01; ns, not significant. For B, P values from Brown Forsythe and Welch ANOVA test. Error bars represent SEM (Standard error mean). For C-D, P values from Fisher’s exact test for WT phenotype and defect phenotype. Given the redundant roles of these proteins in microtubule regulation, we investigated the impact of their simultaneous loss on PLM morphology. Using neuron-specific knockdown of citk-2 in citk-1(ok2328) mutant animals, we observed weakly-penetrant growth defects in the PLM mechanosensory neurons of these animals. As illustrated in two panels of Fig 4A (Inset-2), the loss of citk-2 further declines the length of the posterior process in citk-1(0) animals (Fig 4A and 4B). This synergistic reduction suggests that precise extension of this dendritic-like compartment is regulated by both citk orthologs. In contrast, in citk-1(0) citk-2(kd) animals most of the PLM anterior processes (80 out of 97) displayed wild-type like growth, terminating near or before the ALM cell body (Fig 4A, inset-1). Despite the overall stability of the anterior process, we observed a small fraction of neurons with neurite growth defects, including overgrowth past the ALM cell body or premature termination before vulval opening (short neurite defect) (Fig 4A and 4C). However, quantitative analysis revealed no significant difference in the average length of PLM anterior processes between mutant and wild-type animals (S4E Fig). Furthermore, we observed irregularities in synaptic branch formation in citk-1(0); citk-2(kd) animals. The synaptic branch was either missing or mislocalized in a fraction of PLM neurons. (Fig 4A and 4D). Additionally, these animals displayed ectopic protrusions emanating from the PLM cell body and anterior as well as posterior processes (S4F Fig). The observed structural defects, such as ectopic protrusions and growth defects, are markers of altered microtubule dynamics in the PLM neurons [35,38,45]. Collectively, these findings reinforce the hypothesis that CITK-1 and CITK-2 jointly regulate the microtubule dynamics and, hence, the development of PLM neurons. However, the precise mechanism of this regulation remains unclear. Microcephaly-associated protein ASPM-1 phenocopies the loss of citron kinase proteins CITK-1 and CITK-2 Previous molecular studies have shown that mammalian citron kinase is recruited to spindle poles during cytokinesis by ASPM, a microtubule minus-end-associated protein. It regulates the organization and dynamics of spindle microtubule arrays [56,80]. Additionally, both proteins have been shown to colocalize to the midbody region during cytokinesis [81]. Similarly, the worm orthologue of ASPM, ASPM-1, localizes to the spindle poles and is crucial for spindle pole organization. Consistent with these roles, protein network analysis [82] identified strong predicted interactions between aspm-1 and citk-1 as well as citk-2 (Fig 5A). Drawing on these findings, we hypothesized that citron kinase interacts with ASPM-1 in neurons to regulate microtubule dynamics. Microtubule dynamics and fractional polarity defects observed in aspm-1(ts) mutants. (A) Protein-protein interaction network obtained for citk-1 and citk-2 using STRING database. The nodes represent query and known interacting proteins. Edges represent known and predicted protein-protein functional associations (not necessarily physical interaction) between these proteins or their putative homologs in varied species. The type of association is color coded based on evidence for association such as: Magenta edges (): experimentally determined association based on biochemical or genetic data (including experimental evidence for interaction of putative homologs in other species), Black edges (): co-expression, green edges (): text mining (Co-mentioned in PubMed abstracts). ‘IS’ is the combined interaction score which represents an approximation of confidence in a given association being true, based on all available evidence, on a scale of zero to one. An interaction score of 0.5 or less indicates 50% incidence of false positives. CITK-1 and CITK-2 have no known direct physical association, however, both show interaction with ASPM-1 with a confidence score >0.5 (B-C) Representative kymographs and schematics obtained by plotting the movement of EBP-2::GFP (juIs338) comets in the anterior (B) and posterior (C) processes of PLM neurons (from ROIs mentioned in Fig 3) of the wild-type, aspm-1(ts) and aspm-1(ts); citk-1(ok2328) mutant animals grown at non-permissive temperature of 25°C. (ts) represents temperature sensitive allele of aspm-1. The diagonal lines represent the number of EBP-2::GFP tagged plus-end of microtubules growing away from (green) or towards (purple) the PLM cell body. The slope of the line is the ratio of the growth length(x) and growth duration(y) of a polymerization event. One of the tracks is magnified to compare the growth lengths and growth durations between different genotypes in the anterior process. (D-E) Quantification of the number of growing microtubules/EBP-2::GFP comets in the PLM anterior process (D) and the fraction of minus-end out microtubules in the PLM posterior process (E) in different backgrounds grown at non-permissive temperature. N = 3-4 biological replicates, n (number of neurons) = 12-23. Error bars represent SEM (Standard error mean). For D, E, ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, not significant. P values from Kruskal-Wallis test followed by Dunn’s multiple comparison test. Previous RNAi studies have associated aspm-1 knockdown with embryonic sterility and lethality, similar to the loss of both citk-1 and citk-2 [83]. Therefore, we utilized a temperature-sensitive variant of aspm-1 [84] to characterize its role in regulating microtubule dynamics in neurons. Using the EBP-2::GFP reporter, we observed that aspm-1(ts) mutants exhibit microtubule defects remarkably similar to those seen in citk mutants. Specifically, the PLM anterior process showed a significant increase in the number of growing microtubules (EBP-2::GFP comets) (Fig 5B and 5D). The growth length and duration of these microtubule growth events were significantly reduced compared to wild-type animals (Figs 5B, S5A and S5B). In contrast, PLM posterior processes displayed no change in the number of growth events consistent with the citk mutant phenotype (Fig 5C). Additionally, although the anterior processes showed no change in microtubule polarity (Figs 5B and S5C), the PLM posterior processes displayed a significant increase in the fraction of minus-end-out growing microtubules (Fig 5C and 5E), suggesting a shift in microtubule polarity in aspm-1(ts) mutants similar to that of citk mutants. These defects were rescued by transgenic expression of aspm-1(cDNA) under the touch neuron-specific promoter pmec-4, suggesting a cell-autonomous role for aspm-1 in neuronal microtubule regulation (Figs 5D, 5E, S5A and S5B). Moreover, when we overexpressed the pmec-4::aspm 1(cDNA) transgene in wild-type animals, we observed an increase in microtubule growth length and growth duration in the PLM anterior processes (S5H and S5I Fig). Notably, the fraction of minus-end-out microtubules in the posterior process increases significantly (S5J Fig), mirroring the effects of citk-1 overexpression in wild-type animals (Fig 3D). This suggested role of ASPM-1 in a sustained plus-end growth in the PLM anterior process and dose-dependent regulation of microtubule polarity in PLM posterior process. Therefore, we examined the microtubule plus-end-dynamics in aspm-1(ts); citk-1(0) and aspm-1(ts); citk-2(0) double mutants to evaluate genetic interaction (Fig 5B and 5C). We observed no additive changes in microtubule dynamics or polarity in PLM neurons of these animals, suggesting that aspm-1 works in same genetic pathway as citk-1 (Figs 5D, 5E and S5A–S5C) or citk-2 (S5D–S5G Fig). To further validate that ASPM-1 plays a post-mitotic developmental role in the microtubule regulation of PLM mechanosensory neurons, we subjected aspm-1(ts) mutant animals to the non-permissive temperature from the L1 growth stage (growth condition-II, S6A Fig), after the PLM neurons have already differentiated [43]. The defects in microtubule dynamics displayed by these animals were comparable to the F1 progeny aspm-1(ts) mutant animals who remained at the non-permissive temperature through embryonic development (growth condition-I, S6A Fig) (S6B–S6D Fig). These animals displayed similar shift towards minus-end-out microtubule polarity in PLM posterior process as well (S6G Fig). This suggests that aspm-1 is required post-mitotically for the maintenance of MT dynamics and polarity in differentiated PLM neurons (S5D–S5G Fig). Building on the observations that aspm-1 regulates microtubule dynamics in the PLM mechanosensory neurons, similar to citron kinase mutants, we further evaluated whether it could suppress the klp-7(0) ectopic extension phenotypes [2,29]. As expected, the introduction of aspm-1(ts) mutation in the klp-7(0) mutant background partially suppresses the ALM ectopic extension phenotype (S7A and S7B Fig). Additionally, previous in-vitro studies have shown that ASPM colocalizes with the minus-end binding protein CAMSAP (PTRN-1 homolog) [85,86]. Hence, we investigated whether microtubule minus-end-dynamics or PTRN-1 puncta were perturbed in the PLM neurons of aspm-1(ts) mutant. We found that compared to wild-type animals, aspm-1(ts) mutants showed no change in the number of PTRN-1::GFP puncta in either the anterior or posterior processes of PLM neurons (S7C and S7D Fig). This lack of disruption suggests that ASPM-1 is not required for the proper localization or maintenance of these microtubule minus-end markers. These observations suggest that ASPM-1 works in the same genetic pathway as CITK-1 and CITK-2 to differentially regulate microtubules in the anterior and posterior processes of post-mitotic PLM neurons. Specifically, ASPM-1 regulates microtubule stability in the anterior process and maintains the population of plus-end-out microtubules in the posterior process post-mitotically. CITK-1 and ASPM-1 colocalize with microtubule plus-end binding protein Because both CITK-1 and ASPM-1 influence the microtubule plus-end dynamics but not the minus-end dynamics, we investigated whether these proteins localize to the growing plus ends. Using a TRN-specific promoter, we transgenically co-expressed fluorescent reporters of either CITK-1 or ASPM-1 with the plus-end-binding protein EBP-2 (Fig 6A and 6C). We observed punctate localization of both CITK-1 and ASPM-1 in the cell body and the anterior and posterior processes of PLM neurons (Fig 6A and 6C). Multichannel fluorescence intensity plots revealed that GFP::CITK-1 puncta frequently trail the EBP-2::mCherry peaks (Fig 6A and 6B and S1 Video). Pearson’s correlation analysis confirmed a moderate positive correlation between GFP::CITK-1 and EBP-2::mCherry (Fig 6E), with a similar correlation observed for GFP::ASPM-1 and EBP-2::mCherry (Fig 6C, 6D, 6F and S2 Video). These data suggest a plus-end association for both CITK-1 and ASPM-1 within PLM processes. Localization of CITK-1 and ASPM-1 in PLM neurons displays moderate correlation with MT plus-end protein, EBP-2. (A) Representative confocal images of the PLM mechanosensory neurons in Larval stage-4 animals expressing shrEx550 (pmec-4::gfp::citk-1 + pmec-4::ebp-2::mCherry) in wild-type and aspm-1(ts) mutant background. (B) Representative multichannel plot profile depicting mean intensity value of GFP::CITK-1(depicted in green) and EBP-2::MCherry(depicted in magenta) along the 10um ROI in the anterior process of PLM neuron in wild-type and aspm-1(ts) background. (C) Confocal images depicting PLM mechanosensory neurons in Larval stage-4 animals expressing transgene shrEx552 (pmec-4::gfp::aspm-1 + pmec-4::ebp-2::mCherry) translational reporters in wild-type and citk-1(0) backgrounds. (D) Representative multichannel plot profile depicting mean intensity value of GFP::ASPM-1(depicted in green) and EBP-2::MCherry(depicted in magenta) along the 10um ROI in the anterior process of PLM neuron in wild-type and citk-1(0) background. (E-F) Quantification of Pearson’s correlation coefficient between GFP::CITK-1 and EBP-2::MCherry in WT and aspm-1(ts) backgrounds grown at non-permissive temperature and (E) GFP::ASPM-1 and EBP-2::MCherry in WT and citk-1(0) animals (F) from 30um regions of interest in PLM anterior and posterior process similar to ROIs used in Fig 3. For E, N = 2-3 biological replicates, n (number of neurons) = 6-14. For F, N = 2-3 biological replicates, n(number of neurons) = 5-15. For E and F, Error bars represent SEM (Standard error mean), ***, P < 0.001; **, P < 0.01; *, P < 0.05, ns, not significant. P values from ANOVA with Tukey’s post hoc comparison. Ns, not significant. For Pearson coefficient Correlation coefficient (r) varies from 0.8-1. Given that citk-1 and aspm-1 function in the same genetic pathway, we tested whether their plus-end localization is mutually dependent. We compared the CITK-1 and EBP-2::mCherry correlation between wild-type and aspm-1(0) animals (Fig 6A). We observed no significant changes in the localization pattern or Pearson’s correlation coefficient (Fig 6B and 6E). Similarly, the correlation between ASPM-1 and EBP-2::mCherry remained unchanged in citk-1(0) mutant animals (Fig 6C, 6D and 6F). These observations suggest that CITK-1 and ASPM-1 are associated with and regulate microtubule plus-end dynamics in neurons. However, unlike dividing cells, the localization of CITK and ASPM-1 is independent of each other in the PLM mechanosensory neurons. Discussion In this study, we identified W02B8.2/citk-1, suggested kinase-less orthologue of mammalian citron-rho interacting kinase (CIT), through a genetic modifier screen designed to isolate novel regulators of neuronal microtubule dynamics. Along with its paralog F59A6.5/citk-2, citk-1 plays a redundant and essential role in the development of PLM neurons. These proteins regulate plus-end dynamics in the axon-like anterior process and maintain microtubule polarity in the dendrite-like posterior process of PLM neurons (Fig 7A and 7B). Our findings further demonstrate that the citk-1/2 operate in the same genetic pathway as aspm-1 to modulate microtubule dynamics. Notably, both CITK-1 and ASPM-1 exhibit a positive correlation with the microtubule plus-end binding protein EBP-2 in PLM mechanosensory neurons of C. elegans. Intriguingly, unlike the recruitment hierarchy observed during cell division, the localization of CITK-1 and ASPM-1 at these plus-ends is mutually independent (Fig 7). This suggests that these cytokinesis-associated factors have been repurposed into a specialized regulatory module to maintain the structural integrity of differentiated neurons. Summary and Proposed model. Schematic representation of microtubule dynamics in the anterior and posterior processes of PLM mechanosensory neurons, in the wild-type C. elegans animals (A) and the mutant animals (B). The 30 μm ROI in the anterior process (orange rectangular selection) and posterior process (pink rectangular selection) are zoomed-in to illustrate microtubule dynamics in these processes. The black lines represent microtubules, the sold green circle depicts the growing plus-ends of microtubules, bound by plus-end-binding proteins and the solid purple circle depicts the minus-ends of microtubules. The direction of arrowhead shows the direction of microtubule growth. (A) In the wild-type animals the anterior process exhibits a plus-end-out steady-state microtubule dynamics, while the posterior process displays a mixed microtubule polarity. (B) Similar ROI in mutant animals shows increased microtubule dynamics in the anterior process, schematized as increased number of growing microtubules, and a minus-end-out microtubule polarity in the posterior process. (A’-B’) Schematic representation of microtubule plus end localization of CITK-1 and ASPM-1 protein trailing the plus end binding protein EBP-2. CITK-1 and ASPM-1 promote MT plus-end growth (A’). In the absence of CITK-1 and/or ASPM-1 microtubule plus-ends are more dynamic and are probably exposed to destabilization by KLP-7(Kinesin-13 family protein) (B’). CITK-1 and ASPM-1 maintain axonal microtubule stability in PLM neurons Originally identified as a Rho/Rock effector, Citron-rho interacting kinase(CITK) is a well-established regulator of cytokinesis, specifically through the organization of spindle microtubule arrays and midbody maturation [51]. This function is evolutionarily conserved; in C. elegans, the two suggested CIT orthologues, W02B8.2/citk-1 and F59A6.5/citk-2, function redundantly to ensure developmental viability [66]. Indeed, our attempts to generate viable double homozygotes were unsuccessful, aligning with the reports that their combined loss leads to gonadal sterility and embryonic lethality. Structurally, we found that both CITK-1 and CITK-2 are homologs of the mammalian CIT-N isoform, which specifically lacks the N-terminal kinase domain [51,67]. CIT-N has been shown in vitro to localize in dendrites and soma of hippocampal glutamatergic neurons and GABAergic and glutamatergic neuronal populations of other brain areas, including thalamus, neocortex, and specific populations of cerebellar Pyramidal neurons [51,60]. It has been shown to regulate spine maturation and dendrite morphology in-vitro and in vivo [60,87]. Simultaneous knockdown of both CITK and CITN has also been shown to restrict axon outgrowth in cultured primary hippocampal neurons. CITK knockdown also blocks regeneration in DRGN neurons in-vitro [58]. The regulation of dendritic morphogenesis and neurite extension by the CIT protein has been attributed to Rho mediated modulation of actin [59,61]. Our in vivo findings in PLM neurons expand this understanding. We find that loss of both citk-1 and citk-2 results in shortening of the dendrite-like posterior process and growth defects in the axon-like anterior process of PLM neurons. However, we did not find any major change in actin dynamics in the anterior process of PLM neurons in citk-1(0) mutants. Furthermore, unlike the primarily dendritic localization reported in hippocampal neurons, we found that CITK-1 localizes to the soma and both neuronal processes, suggesting a broader, more integrated role for kinase-less CITK in the structural maintenance of differentiated PLM neurons. While previous studies in dividing HEK cells established that citron kinase regulates the nucleation, stability, and length of astral microtubules [56], our work reveals a specialized post-mitotic role for the kinase-less orthologue in neurons. We found that CITK-1 specifically modulates the microtubule plus-end dynamics in the PLM anterior processes without altering the microtubule polarity in PLM anterior process or the recruitment or maintenance of minus-end out-associated protein PTRN-1. The moderate colocalization we observed between CITK-1 and the plus-end binding protein EBP-2 suggests that CITK-1 selectively regulates the population of dynamic microtubules in PLM neurons. Although the exact molecular mechanism by which CITK confers microtubule stability in the anterior process remains unclear, its presence at the plus-ends suggests it may function as a specialized scaffold or protective cap against depolymerization forces. This model is strongly supported by our genetic evidence, where the loss of citk-1 partially suppresses the ectopic extension phenotype typically observed in klp-7(0) mutants. This suppression implies a functional antagonism between the stabilizing role of CITK and the depolymerizing activity of KLP-7, highlighting a critical balance required for maintaining proper neuronal architecture. During cytokinesis, CITK is specifically enriched in the midbody region through its interactions with the Rho GTPase pathway [ 53,88–91]. Additionally, along with its interacting partners, such as Centralspindilin complex and KIF14, CITK regulates cross-linking and bundling of microtubules to stabilize the midbody architecture [54,92–94]. Our findings raise the intriguing possibility that in the absence of a kinase domain, the worm CITK orthologs retain a functionally analogous scaffolding role in post-mitotic neurons, as the primary drivers of microtubule stabilization. The clinical relevance of these findings is underscored by the association between mutations in mammalian citron kinase and MCPH (autosomal recessive primary microcephaly), a neurodevelopmental disorder characterized by reduced brain size and mild to severe delayed cognitive development and behavioral challenges [48,50]. From studies in CITK-/- mice, these defects were attributed to defects in division of neuronal precursor cells, apoptosis and cell migration [51,95]. In this study we find that loss of citron kinase leads to perturbation in microtubule dynamics and neurite growth in differentiated PLM neurons. These findings suggest that microtubule instability within post-mitotic neurons may be a significant yet understudied contributing factor to the neurological pathologies associated with MCPH. Interestingly, more than 40% of MCPH-associated variants occur within the locus of ASPM, a microtubule minus-end-associated protein. The role of ASPM-1 in meiotic spindle rotation in C. elegans oocytes [84,96], and in symmetric divisions, cell migration and cell fate acquisition in neuronal precursor cells are documented [80,56,81,97,98,99,100,101]. However, its role in differentiated neurons has not been characterized. In dividing HEK cells, ASPM is known to recruit citron kinase to spindle poles, where CITK acts as a vital downstream effector in regulating spindle array dynamics [56]. Our findings demonstrate that ASPM-1 and CITK-1/2 function in the same genetic pathway to limit the number of dynamic microtubules in the axon-like anterior process of PLM mechanosensory neurons. We also find a functional antagonism between ASPM-1 and KLP-7 in the regulation of neurite extension in ALM neurons. By identifying these effects in differentiated cells, we provide evidence that ASPM-1, long considered a mitotic factor, is repurposed in post-mitotic neurons to maintain neuronal microtubule dynamics. This is consistent with an emerging body of literature identifying cytokinesis-associated proteins with essential roles in post-mitotic neurons [102]. CITK and ASPM-1 maintain the plus-end-out microtubule population in the dendrite like posterior neurite of PLM neuron While ASPM, similar to CAMSAP, has been shown to regulate microtubule minus-end dynamics in-vitro [85], our in vivo study reveals a distinct role for the worm orthologue, ASPM-1. We found that ASPM-1, much like CITK-1 and CITK-2, regulates the population of plus-end-out microtubules in the dendrite-like posterior process of PLM neurons. This is in sharp contrast to PTRN-1/CAMSAP, which specifically regulates the minus-end-out population in the same compartment [2]. We found that ASPM-1 and CITK-1/2 operate within the same genetic pathway to govern microtubule polarity in the posterior process of PLM neurons. This is consistent with previous findings in dividing cells, where CIT-K works downstream of ASPM in regulating spindle arrays [56]. Previous studies have also shown that the C-terminal of ASPM coimmunoprecipitated with different myc-tagged CITK fusion proteins, including kinase‐active (FL) or kinase‐dead (KD) full‐length CITK, citron‐N (CN), or the N-terminal or C-terminal half of Citron kinase protein [56]. Furthermore, it has been suggested that the N-terminus of the ASPM protein localizes to centrosomes and spindle poles, and the C-terminus tagged with GFP localizes at the midbody region, enriched with antiparallel arrays of microtubules [81]. This suggests that ASPM can interact with CIT protein irrespective of the kinase domain. Interestingly, we found that both proteins show moderate colocalization with the plus-end binding protein EBP-2. However, their plus-end localization is mutually independent. These findings suggest that while ASPM and CITK epistatically regulate the microtubules in PLM neurons, the mechanistic basis for their recruitment in post-mitotic neurons differs from the hierarchical recruitment observed during cytokinesis. In summary, this study identifies two microcephaly-associated proteins, kinase-less Citron Kinase (CITK-1/2) and ASPM-1, which are functionally repurposed in post-mitotic PLM mechanosensory neurons. While traditionally recognized for their role in cytokinesis, we demonstrate that these factors play a crucial role in regulating microtubule dynamics and polarity, thereby ensuring proper neuronal development. Materials and methods C. elegans genetics C. elegans strains were reared on the standard NGM (nematode growth medium plates) seeded with the E. coli OP50 bacterial strain. For all experimental purposes, worms were maintained at 20°C, with the exception of the temperature-sensitive(ts) aspm-1 strain [103]. For this strain P0 parents were shifted to non-permissive temperature (25°C) at the L4 stage, and their F1 progeny were imaged at the L4 stage. To investigate the post-mitotic role of ASPM-1 in microtubule regulation, L1 larvae were shifted to 25°C and imaged at the L4 stage, thereby bypassing the embryonic loss of ASPM-1 in differentiating PLM neurons. These two paradigms were distinguished as Growth Condition-I and Growth Condition-II, as illustrated in S6A Fig. All experimental controls were also subjected to identical temperature shifts. The (0) denotes the loss of function allele; for instance, the tm2143 deletion allele of klp-7 is mentioned at places as klp-7(0). The strains studied in this paper, including the mutants generated by EMS mutagenesis, are listed in S4 Table. The published transgenes used in this study are listed in S4 Table. The newly generated transgenic strains carrying extrachromosomal arrays of DNA are tabulated in S5 Table. The transgenic lines were generated by microinjection into the gonad of the parent [104]. The homozygosity of mutants was confirmed either by PCR genotyping or by sequencing. EMS mutagenesis The suppressor mutants were generated by EMS mutagenesis [103]. The age-synchronized larval-4 stage animals were pooled and washed thrice with the 1xM9 solution (isotonic salt solution), to get rid of any gut bacteria, following which, the animals were incubated in the 1xM9 solution containing 47mM EMS at 20°C for 4 hours on a hula mixer, which allowed continuous mixing and aeration of media. Post-incubation, the animals were pelleted, and the supernatant was discarded, followed by three washes with 1XM9 solution. Post-wash animals were pelleted, and 6–7 healthy animals were transferred to fresh NGM plates seeded with OP50 bacteria. The resulting F1s were transferred to fresh plates and the F2 generation animals were screened for suppression phenotype. Only one suppressor was picked from one F1 plate. Interestingly, in all cases, the suppression phenotype in one F1 plate was shown by about 25% of the F2 animals, suggesting that the EMS-induced mutations were recessive. The screening was conducted in three batches, as tabulated in S1 Table. Whole genome sequencing mapping analysis The suppressor mutants were backcrossed with the wild-type N2 Bristol strain animals four times [105,106]. In the first three backcrosses, one F3 animal homozygous for klp-7(tm2143) mutation showing the suppression of ectopic extension phenotype similar to the original suppressor mutant was selected. In the fourth backcross, five to ten F3 animals were selected, one from each F2 plate to ensure the selection of unique recombinant animals in this step. The progenies of the homozygous recombinant animals were pooled together to extract the genomic DNA by the isopropanol precipitation method [107]. The library preparation and Illumina sequencing of genomic DNA was outsourced to the Genome Technology Access Centre at McDonnell Genome Institute (MGI), Washington University. They constructed KAPA PCR-free libraries for each sample and sequenced on 0.02 total of a NovaSeq S4 flowcell (300 XP) to obtain paired-end Fastq files. We analyzed the whole genome sequencing data using the tools available on the online Galaxy platform (listed in S6 Table) [108–111]. The default settings were used for the analysis with each tool. The mapping by sequencing guide at https://mimodd.readthedocs.io/en/latest/nacreousmap.html [109,111] was used to design the workflow for the analysis. The tools in S6 Table are listed in the order they were used for analysis. Sequencing of citk-1(ok2328) allele For sequencing the mutant allele, we reverse transcribed the RNA isolated from the mutant animals. As previously described the about to be starved plates of mutant animals, which contained animals from all life stages, were washed with 1xM9 buffer thrice. The worm pellet was collected and stored at -80°C for RNA isolation. Using the Qiagen RNeasy Mini kit (no. 74104; Qiagen) RNA was isolated from the thawed pellet. The isolated RNA was treated with DNase I (Ambion’s DNA-free kit AM1906) to get rid of any genomic DNA contamination. Around 3–4 µg of this RNA was then reverse transcribed into cDNA using Superscript III Reverse Transcriptase (18080093). Wild-type cDNA was also isolated and processed as a control. The sequencing of the mutated region of this cDNA was outsourced to ATGC sequencing facility at Regional Centre for Biotechnology, Faridabad, India. The sequencing confirmed that ok2328 deletion mutation is a frameshift variant as the 16 bp insert (CCTATACTTACCTCAG) is incorporated in cDNA in the place of deleted segment, which introduces a premature stop codon after 635th amino-acid. Immobilization of worms for imaging experiments The fourth larval staged worms (L4) expressing fluorescent reporters were immobilized and mounted on 5% agarose pads using 10 mM Levamisole (Sigma-Aldrich; L3008) for widefield fluorescence imaging. For confocal scanning worms were mounted on 7.5% agarose pads. We immobilized the worms for EBP-2::GFP reporter live imaging using 0.1-μm polystyrene bead suspension (Polysciences; 00876–15) on 15% agarose pads. The agarose was dissolved in 1XM9 buffer as described in previously used protocols [29]. Widefield fluorescence imaging of mechanosensory neurons for quantifying developmental defects The ALM and PLM neurons were visualized using a fluorescent reporter expressed under a mechanosensory neuron-specific reporter pmec-7::GFP (muIs32) using a Leica DM5000 B fluorescent microscope with a 40X air objective (NA 0.75). The L4 staged animals were mounted on 5% agarose beds and immobilized in 10mM Levamisole (Sigma-Aldrich; L3008) in 1XM9 buffer. The morphology of ALM neurons in klp-7(0) and suppressor mutants was qualitatively scored based on their microscopic appearance. The posterior neurite of the ALM neuron was considered a mild ectopic extension if it ended before the vulva and a strong ectopic extension if it crossed the vulva. This method was used to calculate the percentage of neurites showing the ectopic extension phenotype. Image acquisition and analysis of neurite length of mechanosensory neurons using a point-scanning confocal microscope The mechanosensory neurons were visualized by expressing a fluorescent protein under a touch neuron-specific promoter either pmec-7::GFP (muIs32) or pmec-4::RFP (tbIs222). All the phenotyping or imaging experiments were performed with L4 stage animals using a Nikon confocal microscope (A1HD25) with a 60X oil objective (NA 1.4). The 1.5% of a 488nm laser was used to image GFP-tagged animals and 5% of a 561nm laser was used to image RFP-tagged animals along with a simultaneous differential interference contrast image. To quantify the absolute and relative lengths of the anterior and posterior processes of PLM we used ImageJ software (Figs 2D, 4B, S4B–S4E and S5E). It was used to draw segmented traces along the length of the process in fluorescent channel ImageJ and then measure the length of the trace/process. The measured length of the anterior process of PLM was normalized by the length of the trace drawn between the anal opening and the vulva of the corresponding animal, measured from the differential interference contrast image. To normalize the length of the posterior process of PLM its value was divided by the length of a trace drawn from the anal opening to the tip of the tail. 3-D protein modeling The protein structure predictions were modeled using the Alphafold2 [112,113,114] on the Galaxy platform (https://usegalaxy.eu/) [108]. The molecular graphics and analysis were performed using Chimera [115] (S1C, S1D, S2E and S2F Figs). Molecular cloning and the generation of new transgene The pNBR77 pCR8::citk-1 and pNBR82 pCR8::aspm-1 constructs were generated by cloning PCR amplified full length cDNAs in linearized pCR8 vectors by Infusion cloning (Takara, 638947). The citk-1 cDNA was amplified using the primers AGR733 (5’ CCGAATTCGCCCTTATGAACGAATCAATATATACAACGC 3’) and AGR734 (5’ GTCGAATTCGCCCTTTTAGTTTTTGGATCTTTTCAATGT 3’) from yk2046g11. The aspm-1 cDNA was amplified using the primers AGR1218 (5’ TCCGAATTCGCCCTTATGGATAATAACGTTGAGG 3’) and AGR1219 (5’ GTCGAATTCGCCCTTTTAGAGCATATCTTCGCATATG 3’) from yk3075k20. The pCR8 cloning vector was linearized using the primers AGR607 (5’ AAGGGCGAATTCGAC 3’) and AGR608 (5’ AAGGGCGAATTCGAC 3’). The pNBR77 pCR8::citk-1 and pNBR82 pCR8::aspm-1 constructs were then recombined with appropriate destination gateway vectors (pmec-4::gay and pmec-4::gfp::gwy) by single site LR recombination using an LR clonase enzyme (Invitrogen;11791–020) to construct pNBRGWY160 (pmec-4::citk-1), pNBRGWY199 (pmec-4::gfp::citk-1) pNBRGWY190 (pmec-4::aspm-1) and pNBRGWY193 (pmec-4::gfp::aspm-1). The clones were then injected at 1–5ng/µl to generate transgenic animals. pmec-4::ebp-2::mCherry is a gift from Dr Yishi Jin lab. pttx-3::RFP or pmyo-2::mCherry was used as a coinjection marker at concentrations of 60 ng/µl or 2.5ng/µl, respectively, to generate transgenic strains. The injection mixture was brought to a total concentration of 110–120 ng/μl by adding pBluescript (pBSK) plasmid to the injection mixture. Blast analysis The reciprocal blast analysis was conducted for the citk-1 protein sequence using the online NCBI protein blast platform [116,117]. The algorithm parameters were set at their default settings. The taxon-specific blast results were conducted for reciprocal blast analysis [116–118] (S2C Fig). Foldseek analysis The Foldseek structural analysis was performed at default parameters in 3Di/AA mode using the online Foldseek search server [119]. The taxonomic filter was used for the taxon-specific blast results [120]. Protein sequence alignment The M-coffee server (https://tcoffee.crg.eu/apps/tcoffee/do:mcoffee) was used to align the protein sequences obtained from UniProt server [64,121]. SIAS was used to compare sequence similarity and sequence identity (http://imed.med.ucm.es/Tools/sias.html). Results of alignment can be seen in S1 Appendix. RNAi experiments As the double mutant of citk-1(ok2328) and citk-2(ok2885) could not be generated a neuron-specific knockdown of citk-2 in citk-1 mutant was performed using a well-established RNAi by feeding method in worms [70–74,122] (Figs 3, 4, S3 and S4). We used an RNAi-sensitive strain lin-15b(n744)X; tbIs222(pmec-4::mCherry); shrSi2[pmec-3::sid-1, Cbunc-119(+)]II, with a neuron-specific expression of a transmembrane dsRNA transporter sid-1 under the touch neuron-specific promoter (pmec-3) [74] and a gentle touch neuron-specific fluorescent reporter pmec-4::RFP (tbIs222). The worms were fed on HT115 E. coli bacteria expressing dsRNA for knockdown of gene of interest. As a positive control, the knockdown of dhc-1 and ama-1 was tested in this strain. The RNAi of dhc-1(dynein heavy chain-1) successfully produced dead embryos [123] and RNAi of ama-1(encodes the large subunit of RNA polymerase-II) resulted in L1 (larval stage-1) arrest phenotype [124] with a 100% penetrance. The negative control for RNAi was the HT115 bacterial strain with empty plasmid L4440. The positive control for neuronal RNAi was unc-22 (regulates muscle contraction and relaxation) [125–127], and for gentle touch neuron-specific RNAi was mec-4 (allows ligand-gated Na channel activity and is required for gentle touch sensation) [128–130], which successfully resulted in twitching (100% penetrance) and loss of gentle touch sensation phenotype (60% penetrance), respectively. The bacterial strains carrying the dsRNA used in this work are a part of Ahringer’s library [72], which was purchased from Source Bioscience (3318_Cel_RNAi_complete). The bacterial culture and feeding were performed as described in a recent paper from our lab [74]. Each dsRNA bacterial strain was grown in 4.5 ml of LB nutrient broth with Carbenicillin (50mg/ml) and Tetracycline (12.5mg/ml) antibiotics to an OD of 0.8-0.9. Once this OD was achieved, bacterial culture was centrifuged and the pellet was resuspended in 1 ml of 1XM9 containing 50mg/ml Carbenicillin, 12.5mg/ml Tetracycline, and 1.5mM IPTG. A 250µl of this bacterial suspension was used for seeding NGM plates (containing 50mg/ml Carbenicillin, 12.5mg/ml Tetracycline, and 1.5mM IPTG), followed by a 36 hrs. incubation at 25°C. 5–6 L3s were transferred to these plates, and their progenies were imaged. Live imaging and analysis of EBP-2::GFP dynamics We used Nikon Ti2 widefield fluorescence microscope equipped with an Andor Zyla VSC-02284 Camera with a 560MHz readout rate for time lapse image acquisition. We captured the images at a 400ms exposure rate, a gain of 4 and 2x2 binning in a frame of 1280 × 1060 pixels using a Plan Apo VC 100 × Oil/1.4 NA objective at a frame rate of 2.44 frames per second for 2 minutes’ duration. The EBP-2::GFP imaging for RNAi experiments in Fig 3 was conducted using ZEN2 Blue software on a Zeiss Observer Z1 microscope equipped with a Yokogawa CSU-XA1 spinning disk confocal head and a Photometric Evolve electron-multiplying charge-coupled device camera for fast time-lapse image acquisition. We captured the images in a frame of 120 × 120 μm2 (512 × 512 pixels2) using a 100 × /1.46 NA objective at a frame rate of 2.64 frames per second for 2 minutes’ duration. We used 8.75mW of a 488-nm excitation laser to achieve the best signal-to-noise ratio for EBP-2::GFP. To analyze the captured time-lapse images, we generated kymographs using the Plugins/ KymoReslice-Wide/Max Intensity Projection tool (https://github.com/UU-cellbiology/KymoResliceWide) [131,132] (https://imagej.nih.gov/ij/). The kymographs were generated from two 30-μm ROIs one from the PLM anterior (from the 30u distal end to the cell body) and the other from the posterior process (from the cell body to the distal end at 30u). Kymographs are distance v/s time plots with distance along the X-axis representing axon length in micrometers and time in seconds along the Y-axis. The movement of an EBP-2::GFP comet along the axon length in a kymograph is observed as a diagonal line. We annotated the diagonal lines moving away from the cell body as “plus-end-out” microtubules (+), and the lines moving towards the cell body were annotated as “minus-end-out” microtubules (-). The fraction polarity was calculated as the relative number of plus-end-out or minus-end-out growing microtubules to the total number of microtubules. The growth length and growth duration were calculated from the slope of these tracks by using the analysis tool of ImageJ. Imaging and analysis of PTRN-1::GFP puncta Using the 488nm laser of the point scanning Nikon Confocal AXR microscope, we acquired the Z-stacks of PLM neurons expressing pmec-4::GFP::PTRN-1 from both wild-type and mutant animals. Images were acquired using 100X 1.45 NA oil objective. Animals were immobilized using 10mM Levamisole and mounted on 7.5% agarose. The maximum intensity projection image was background-subtracted and used to obtain the line profile of pmec-4::GFP::PTRN-1 puncta using the ImageJ line-profile tool. The peaks in 30µm of the anterior and posterior processes were identified from line profile using the BAR plugin of ImageJ. We counted all peaks above a minimum peak amplitude of 1 for an unbiased count of PTRN-1::GFP puncta. Actin imaging and kymograph analysis Time-lapse imaging of GFP::UtCH was performed using an Olympus IX83 microscope equipped with a Yokogawa CSU-W1 spinning-disk confocal module and a Prime BSI back-illuminated sCMOS camera. Excitation was provided by a 488 nm solid-state laser operated at 5% power. Images were acquired using a 100 × /1.4 NA oil objective. This optical configuration, including the SoRa module and 2 × 2 camera binning during acquisition, resulted in an effective pixel size of 0.13 µm per pixel. A region of the proximal axon of the PLM (posterior lateral mechanosensory) neuron, anterior to the axonal branch point, was imaged. Time-lapse movies were acquired for 180 s at a frame rate of 1 frame per second with an exposure time of 300 ms. Kymographs were generated from time-lapse movies using the Multi Kymograph plugin in FIJI/ImageJ. As in [79], actin polymerization events were identified and quantified as the number of events per 100 µm of axon length per minute. In kymographs, polymerization events were defined as diagonal trajectories indicative of movement, either anterograde or retrograde, that sustained across multiple frames. Events were included for analysis only if the region that polymerized earlier persisted at later time points, resulting in a triangular region of uniform intensity over the duration of the event. Apparent diagonal lines arising from the juxtaposition of stationary (vertical) regions were not counted. Transient diagonal streaks or brief intensity fluctuations giving the appearance of diagonal trajectories were excluded. Only events with uniform fluorescence intensity throughout their duration were scored, reflecting filament elongation rather than cargo movement. Each polymerization event was counted once, at initiation. Imaging and Analysis of GFP::CITK-1, GFP::ASPM-1 and EBP-2::mCherry puncta Animals were immobilized using polystyrene beads and mounted on 15% agarose. Using the 100X1.54 NA oil objective of point scanning Nikon Confocal AXR microscope, we acquired the Z-stacks of PLM neurons expressing shrEx550(pmec-4::gfp::citk-1 + pmec-4::ebp-2::mCherry) or shrEx552(pmec-4::gfp::aspm-1 + pmec-4::ebp-2::mCherry) from both wild-type and mutant animals. GFP::ASPM-1 was imaged using 20% of 488 nm laser and EBP-2::MCherry was imaged using 10% of a 561nm laser for the shrEx552 allele. GFP::CITK-1 was imaged using 25% of a 488nm laser and EBP-2::mCherry was imaged using 15% of 561nm laser for the shrEx550 allele. An image was analyzed only if both EBP-2::mCherry and GFP::CITK-1/ GFP::ASPM-1 are in focus. A single Z-slice with PLM neurite in focus in both channels was extracted and background subtracted. The multichannel slice was then split into two channels. Using the segmented line tool a 30µm trace was drawn along the PLM anterior/posterior process. This line is added to ROI for colocalization analysis using Coloc2 tool. Using default settings of this tool hundred Costes’ randomizations were performed to analyze Pearson’s correlation coefficient. The multichannel plot profile was generated using the BAR plugin of ImageJ. Live Imaging and Analysis of GFP::CITK-1, GFP::ASPM-1 and EBP-2::mCherry puncta Animals were mounted on 15% agarose and immobilized in polystyrene beads. Using the 100X1.54 NA oil objective of point scanning Nikon Confocal AXR microscope, we acquired time-lapse live images of PLM neurons expressing shrEx550(pmec-4::gfp::citk-1 + pmec-4::ebp-2::mCherry) or shrEx552(pmec-4::gfp::aspm-1 + pmec-4::ebp-2::mCherry) from both wild-type and mutant animals. shr550 was imaged at 1024X512 resolution with a line averaging of 8X, dwell time 0.4us. GFP::CITK-1 was imaged using 25% of a 488nm laser (Gain 80 and offset = 0) and EBP-2::mCherry was imaged using 15% of 561nm laser (Gain 80 and offset = 0) for the shrEx550 allele. shr552 was imaged at 512X512 resolution with a line averaging of 2X, dwell time 1us. GFP::ASPM-1 was imaged at using 20% of 488 nm laser (Gain 45 and offset = 0) and EBP-2::MCherry was imaged using 10% of a 561nm laser (Gain 40 and offset = 0) for the shrEx552 allele. An image was processed only if both EBP-2::mCherry and GFP::CITK-1/ GFP::ASPM-1 are in focus. Images with PLM neurite in focus in both channels were bleach corrected, background subtracted and binned for visualization (See S1 and S2 Video files). Statistical analysis We plotted and analyzed data using GraphPad Prism software version 9.0.2 and 9.5.1. The details of methods and statistical tests used for comparisons are given in Fig legends. The contingency plots represent the percentage of neurites showing characterized phenotypes. The bar plots represent mean and standard error of mean (SEM) for respective samples. The X2 test (Fisher’s exact test) was used to compare proportions. The normality of data was assessed using Shapiro-Wilk test. For Normally distributed data Bartlett’s test was performed to compare variance across samples followed by Brown Forsythe and Welch ANOVA test as samples showed significant difference between variances. For samples that did not pass the normality test, the comparison was performed using Mann Whitney test for two groups or Kruskal Wallis with a post-hoc Dunn’s multiple comparison test for multiple groups. In each Fig panel, P values are provided for intergroup comparisons. The respective sample size (n) and the total number of biological replicates (N) is also mentioned in the Fig legends. Supporting information No. of F1s screened. (XLSX) Identified SNPs in suppressor mutants. (XLSX) Descriptive results of blast analysis of citk-1. (XLSX) Strains used in this study. (XLSX) Transgenes generated. (XLSX) Tools used for analysis of WGS data. (XLSX) The sequence alignment of worm citk-1 and citk-2 with mammalian CIT proteins. (DOCX) Related to Fig 1: Isolated variants in mec-7 (β-tubulin) and mec-12 (α-tubulin) that suppress klp-7(0). (A-B) Two-dimensional schematic illustration of the exon and intron of the mec-7 and mec-12 gene and protein structures with positions of identified candidate mutations labeled. The scale bar is in bp (base pairs). mec-7 and mec-12 gene. The mec-7(shr20) and mec-7(shr15) variants are in the nucleotide binding domain of the MEC-7 protein. The shr25 is a splice site acceptor variant at the junction of intron-2 and exon-3 which may influence RNA splicing and in effect MEC-7 protein folding or protein synthesis. The mec-12(shr9), mec-12(shr19), mec-12(shr10) and mec-12(shr1) variants are in the GTPase domain of protein and the mec-12(shr17), and mec-12(shr21) variants are in the C-terminal 2-layer sandwich domain (B). (C-D) Alphafold [112,113,114] generated three-dimensional schematics of a MEC-7 and MEC-12 tubulin dimer with locations of klp-7(0) suppressor variants highlighted in magenta using Chimera [115] and rotated to display front and back views of the dimer. As depicted in Fig C and D, the mec-7(shr15) mutation introduces a premature stop codon, a truncated protein if formed will lack the entire α-tubulin binding domain. The non-conservative mutations in the nucleotide binding pocket of protein like mec-7(G148R), mec-12(G148S) and mec-12(G143E) replace a simple flexible glycine amino acid with complex amino acids with positively (arginine) or negatively (glutamic acid) charged side chains or polar side chains with hydroxyl group (serine) might lead to steric hindrance and hence nucleotide binding and protein folding. The mec-12 mutation P32S is in the P loop and the G321R, S277L are present on the inter-dimer surface. These substitutions likely impact microtubule polymerization, nucleotide binding, or heterodimer interactions. The mec-12(C129Y) mutation replaces a small cysteine nucleotide capable of forming disulfide bonds with a large polar and aromatic tyrosine in interdimer surface. The mutation could disrupt the protein structure or stability or could even influence interdimer interactions. These effects on protein could eventually lead to changes in the fifteen protofilament architecture of microtubules in the mechanosensory neurons. (TIFF) Related to Fig 2: Mapping and characterization of shr11 variant. (A) Normalized variant density plot of Chromosome II obtained by EMS density mapping analysis of shr11 variant from the whole genome sequencing data using the method described in [110]. The variant density is normalized as the number of EMS induced variants per 500Mb (gray bars) along the chromosomal length in Mb. It peaks at the genomic position linked to shr11 variant. (B) Quantification of the percentage of ALM exhibiting ectopic extension phenotype in the wild-type, klp-7(0), klp-7(0); citk-1(shr11), klp-7(0); citk-1(shr11); citk-1(genomic DNA)[+] backgrounds, where citk-1 (genomic DNA) is the fosmid WRM062dD08. N = 3–5 independent replicates, n (number of neurons) = 45–60. P values from 2x2 Fischer’s exact test. (C-D) Quantification of the normalized length of PLM posterior process in (C) klp-7(0), citk-1(shr11); klp-7(0), citk-1(ok2328); klp-7(0), citk-1(shr11); klp-7(0); citk-1 genomic DNA [+] and citk-1(shr11); klp-7(0); citk-1 cDNA [+] where genomic citk-1 is the citk-1 fosmid WRM062dD08 and the citk-1(cDNA) is expressed under mechanosensory neuron specific promoter pmec-4 and in (D) klp-7(0) and citk-2(ok2885); klp-7(0) backgrounds. Normalized length of PLM posterior = (Absolute length/distance between the PLM cell body to the tip of the tail for the posterior neurite). For (D) N = 3–4 independent replicates, n (number of neurons) = 11–50. P values from Kruskal Wallis test followed by Dunn’s multiple comparisons. For (E) N = 3–4 independent replicates, n (number of neurons) = 42–45. (E) Graphical overview of the distribution of top blast hits [117] on the query sequence, W02B8.2/CITK-1, represented by the pink bar. The hits are shown aligned to the regions of query, below in color coded bars. (F) Heat map showing the percentage similarity and percentage identity shared between citron rho interacting kinase proteins from different species. (G) The Alphafold predicted structures of CITK-1, CITK-2, and the kinase-less isoform of mammalian CIT (CIT-N). The inset shows the pleckstrin-homology domain (blue) and the citron-homology domain (magenta). The matrix on the right shows the expected position error in the predicted structures as given by Alphafold. (H) The Foldseek [119] predicted structural alignments and Tm alignment scores between CITK-1 and CITK-2, CITK-1 and CIT-N, and CITK-2 and CIT-N. Tm (Template modelling score) is a quantitative measure of protein structure similarity and lies between the values 0 and 1, where 1 indicates a perfect match. A Tm score below 0.3 indicates a random structural similarity [133]. (I-J) The schematic of the exons and introns of the (I) citk-1 and (J) citk-2 gene and the genomic positions of (I) shr11, ok2328 and (J) ok2885 alleles in the gene locus. Below the gene structure is the schematic of (I) CITK 1 and (J) CITK-2 proteins and the deleted regions in the (I) ok2328 and (J) ok2885 alleles. (K) Quantification of absolute length of ALM posterior process in wild-type control and in wild-type animals with transgenic overexpression of shrEx463(Pmec-4::citk-1). PLM neurons were visualized using muIs32(Pmec-7::GFP) transgene. N = 2 independent replicates, n (number of neurons) = 25–50. P values from student’s T-test. For D-E, K, Error bars represent SEM (Standard error mean), ***, P < 0.001; **, P < 0.01, *, P < 0.05, ns, not significant. (TIFF) Related to Fig 3: Microtubules are more dynamic in the PLM anterior process of citk mutant animals. (A-B) Histograms depicting the growth length (A) and growth duration (B) quantified by determining the net pixel shift in the X and Y axis of kymographs obtained from PLM anterior processes of same backgrounds as Fig 3. N = 3–5 independent replicates, n (number of tracks) = 120–1081. (C) Quantification of fraction of plus-end-out microtubules (number of plus-end-out MTs/Total number of MTs) in the anterior process of given backgrounds. N = 3–5 independent replicates, n (number of tracks) = 6–18 (D) Quantification of number of growing microtubules per kymograph in the posterior process of PLM neurons for A-D, N = 3 independent replicates, n (number of neurons) = 6–26. (E) Representative confocal images of PLM neurons in L4 staged wild-type and citk-1(0) animals expressing transgene juEx6455(pmec-4::gfp::ptrn-1). Black arrowheads point to GFP::PTRN-1 puncta. The blue and orange dotted rectangle represent the 30µm ROI in the anterior and posterior process of PLM neuron. (F) Quantification of the number of GFP-PTRN-1 puncta seen in the 30µm ROIs in the anterior and posterior process of PLM neurons (as shown in Fig 3A and 3B). (G-H) Representative kymographs obtained by time lapse live imaging of PLM neurons expressing actin reporter, GFP::UtCH (G) and quantification of the actin trail density/100um/min in distal region of PLM neurons in WT and citk-1(0) animals (A-D, F, H) ***, P < 0.001; **, P < 0.01; *, P < 0.05, (A-D) P values from Kruskal Wallis test followed by Dunn’s multiple comparison test. The groups separated by dotted lines were analyzed independent of each other. (F) P values from ANOVA with Tukey’s multiple comparison test. (H) P values from Mann Whitney U Test. (A-D, F) Error bars represent SEM (Standard error mean), ns, not significant. (TIFF) Related to Fig 4: citk-1 single mutants display a short PLM posterior process. (A-A’) Representative confocal images and schematics of the ALM and PLM mechanosensory neurons in L4 stage wild-type and citk-1(ok2328) mutant animals. These neurons are labeled by muIs32(pmec-7::GFP) reporter. A dotted blue arrow marks the distal tip of PLM anterior process. The white arrow points to the ventral synaptic branch. White double-headed arrow is drawn along the length of PLM posterior process. Vulva on the ventral side of animal is marked by an asterisk (*), and anus is marked by a generic symbol (¤). (B-C) Quantification of the normalized length of PLM posterior process (B) and anterior process (C) in the wild-type, citk-1(shr11), citk-1(ok2328) and citk-2(ok2885) animals. (The PLM posterior process was also rescued by shrEx514(Pcitk-1::citk-1), extrachromosomal expression of a fosmid, WRM062dD08, containing complete genomic locus of citk-1, in citk-1(ok2328) mutant animals as quantified in (B). For B-C, N = 3–5 independent replicates, n (number of neurons) = 30–48. (D) Quantification of percentage of PLM neurons displaying a defect in the positioning or count of ventral synaptic branch in the wild-type, citk-1(shr11), citk-1(ok2328) and citk-2(ok2885) mutant animals. N = 3–5 independent replicates, n (number of neurons) = 51–68. (E) Quantification of the normalized length of PLM anterior process in the wild-type control and citk-1(0) RNAi sensitive background animals fed on bacteria expressing either empty vector (control) or citk-1 or citk-2 ds RNA for RNAi mediated knockdown. N = 3–5 independent replicates, n (number of neurons) = 17–34. (F) Quantification of number of short ectopic protrusions/ PLM neuron anterior process in the wild-type control and citk-1(0) RNAi sensitive background animals fed on bacteria expressing either empty vector (control) or citk-1 or citk-2 ds RNA for RNAi mediated knockdown. N = 3–5 independent replicates, n (number of neurons) = 32–56. Error bars represent SEM (Standard error mean), ns, not significant; ***, P < 0.001; **, P < 0.01; *, P < 0.05. For B-C and E-F, P values from Kruskal Wallis test followed by Dunn’s multiple comparison. For D, P values from 2x2 Fisher’s exact test. (TIF) Related to Fig 5: ASPM-1 works in the same genetic pathway as CITK-1 and CITK-2. (A-B) Histograms depicting the growth length (A) and growth duration (B) of the EBP-2::GFP bound microtubules in the anterior process of PLM neurons in the wild-type and aspm-1(0) mutants, quantified by determining the net pixel shift in the X and Y axis (of kymographs) respectively. (C) Plot of fraction of plus-end out microtubules in PLM anterior process of respective genotypes. The wild-type, aspm-1(ts), aspm-1(ts); shrEx546(+), citk-1(0) and aspm-1(ts); citk-1(0) animals were grown at non-permissive temperature of 25°C. shrEx546 transgene expresses pmec-4::aspm-1. For A-C, N = 3–4 independent replicates, for A-B, n (number of tracks) = 112–756. P values from Kruskal Wallis test followed by Dunn’s multiple comparison and for C, n (number of PLM neurons) = 13–29. (D-G) Quantification of microtubule growth parameters (D-F) and fraction polarity (G) in PLM neurons of wild-type, aspm-1(ts), citk-2(ok2885) and aspm-1(ts); citk-2(ok2885) mutant backgrounds reared at non-permissive temperature of 25°C. For D-G, N = 3–4 independent replicates, for D, G, n (number of PLM neurons) = 12–23 and for E-F, n (number of tracks) = 512–1665. For D-G, P values from Kruskal Wallis test followed by Dunn’s multiple comparison. (H-J) Quantification of microtubule growth length(H), growth duration(I), and fraction polarity(J) in the anterior and posterior processes of WT and WT animals overexpressing aspm-1 as transgene shrEx530(pmec-4::aspm-1)(++). For H-J, N = 3 biological replicates, for H-I, n(no. of tracks) = 349–871 and for J, n(number of neurons) = 12–18. All animals in A-B and D-I express transgene juIs338(pmec-4::EBP-2::GFP). For H-J, P values from unpaired Student’s T-test. Error bars represent SEM (Standard error mean), ns, not significant; ***, P < 0.001; **, P < 0.01; *, P < 0.05. (TIFF) Related to Fig 5: ASPM-1 is required in post-mitotic PLM neurons to regulate microtubule dynamics. (A) Schematic illustrating control and test growth condition-1 and 2 animals were subjected-to for experiments in B-G. Animal growth condition-1 in pink illustrated rearing of animals at 25°C. Animal growth condition-2 in sky blue illustrates animals reared at 20°C. L1 progeny of these animals is transferred and grown to L4 stage at 25°C for experiments. (B-G) Quantification of microtubule growth parameters in PLM neurons of WT and aspm-1(ts), in control or test conditions. Kymographs were obtained from same ROI as described in Fig 3. The color of the background panel denotes the growth condition for respective datasets. For B-G, N = 3–4 biological replicates, For B, E-G, n(number of neurons) = 12–24, for C-D, n(number of tracks) = 805–1667. All animals in B-G express transgene juIs338(pmec-4::EBP-2::GFP). For B-G, Error bars represent SEM (Standard error mean), ns, not significant; ***, P < 0.001; **, P < 0.01; *, P < 0.05, P values from Kruskal Wallis test followed by Dunn’s multiple comparison. (TIFF) Related to Fig 5: ASPM-1 mutation can suppress klp-7(0) ectopic extension phenotype. (A-B) Representative confocal images of ALM and PLM neurons in L4 staged klp-7(0) and aspm-1(0); klp-7(0) mutant animals grown at non-permissive temperature. The neurons are labeled by muIs32(pmec-7::GFP) reporter. However, the image has been inverted in ImageJ for presentation purposes. The ALM extends two mild posterior extensions (pink arrowhead) in klp-7(0) animal. The aspm-1(0); klp-7(0) double mutant shows no extension. The blue dotted arrow marks the distal tip of anterior process of PLM neuron, and the black double-headed arrow is drawn along the length of the PLM posterior process. Black solid arrows point to ventrally extended synaptic branches. (B) Quantification of the length of ALM posterior process in klp-7(0), aspm-1(ts) and aspm-1(ts); klp-7(0) mutants. N = 3 and n (number of neurons) = 21–46. (C) Representative confocal image showing distribution of PTRN-1::GFP puncta in the anterior and posterior process of PLM neurons in WT and aspm-1(ts) animals expressing transgene juEx6455(pmec-4::gfp::ptrn-1). The animals were reared at 25°C. The blue and orange dotted rectangle represent the 30µm ROI in the anterior and posterior process of PLM neuron. Black arrowheads point to GFP::PTRN-1 puncta. (D) Quantification of number of GFP::PTRN-1 puncta in WT and aspm-1(ts) grown at 20°C (in sky blue) and 25°C(in pink). The number of GFP::PTRN-1 puncta were quantified from 30µm ROI. N = 3 and n (number of neurons) = 15–23. For B, D Error bars represent SEM (Standard error mean). ***, P < 0.001; **, P < 0.01; * P < 0.05 and ns, not significant. For B, P values from Kruskal Wallis test followed by Dunn’s multiple comparison. For D, P values from ANOVA with Tukey’s multiple comparison test. (TIFF) Related to Fig 6: Live Imaging of GFP::CITK-1 and EBP-2::mCherry. The representative time-lapse video of GFP::CITK-1(in green) and EBP-2::MCherry(in magenta) tracks in anterior processes of PLM neurons in WT background. EBP-2::mCherry associates with the growing plus-ends of microtubules. White arrows track the EBP-2::mCherry colocalized GFP::CITK-1 comets (in white), moving away from the cell body. Videos were captured using a Nikon AXR point-scan confocal microscope at a speed of 1.48 frames per second and played at 7 frames per second. (MP4) Related to Fig 6: Live Imaging of GFP::ASPM-1 and EBP-2::mCherry. The representative time-lapse video of GFP::ASPM-1(in green) and EBP-2::MCherry(in magenta) tracks in anterior processes of PLM neurons in WT background. White arrows track the EBP-2::mCherry(MT plus ends) colocalized GFP::ASPM-1 comets (in white), moving away from the cell body. Videos were captured using a Nikon AXR point-scan confocal microscope at a speed of 1 frame per second and played at 7 frames per second. (MP4) 13 Jun 2025 PGENETICS-D-25-00512 The cytokinesis associated proteins CITK and ASPM-1 regulate neuronal microtubule dynamics and polarity in C. elegans. PLOS Genetics Dear Dr. Ghosh-Roy, Thank you for submitting your manuscript to PLOS Genetics. After careful consideration, we feel that it has merit but does not fully meet PLOS Genetics's publication criteria as it currently stands. In particular, reviewers raised questions about whether ASPM-1 and CITK-1/2 function in the same pathway (suggesting genetic tests to examine this); whether the worm proteins examined were true paralogs of the human proteins; and had concerns with the clarity of the writing. We invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 60 days Aug 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Jeremy Nance Academic Editor PLOS Genetics Pablo Wappner Section Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics Journal Requirements: 1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full. At this stage, the following Authors/Authors require contributions: Sunanda Sharma, Keerthana Ponniah, and Anindya Ghosh-Roy. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form. The list of CRediT author contributions may be found here: https://journals.plos.org/plosgenetics/s/authorship#loc-author-contributions 2) Please provide an Author Summary. This should appear in your manuscript between the Abstract (if applicable) and the Introduction, and should be 150-200 words long. The aim should be to make your findings accessible to a wide audience that includes both scientists and non-scientists. Sample summaries can be found on our website under Submission Guidelines: https://journals.plos.org/plosgenetics/s/submission-guidelines#loc-parts-of-a-submission 3) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: https://journals.plos.org/plosgenetics/s/figures 4) We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list. 5) Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well. State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.". If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d Reviewers' comments: Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: Review is uploaded as an attachment Reviewer #2: The authors use an elegant forward genetic screen to identify modulators of neurite outgrowth linked to microtubule growth in neurons using the advantages of C. elegans. Using a suppressor screen, they identify citk as a regulator of neurite outgrowth through modulation of microtubule growth dynamics/stability. This is a unique role for this protein previously studied primarily as a regulator of cell division previously. The role of citk in neurite extension is further supported by the fact that ASPM, a protein that functions with CITK during cell division, causes similar defects in neurons when mutated. Together, this data argues for roles for these cell division-associated proteins in post-mitotic neurons. Despite my original enthusiasm for this work, there are some missing pieces that are required to provide mechanistic insight into how CITK functions to regulate microtubules and neurite outgrowth. Furthermore, the homology between W02B8.2 and CITK should be confirmed by rescue analysis with a mammalian ortholog. Finally, on a more stylistic point, the writing is drawn out and needs to be more pointed. Long sentences are elegant but, in some cases, the meaning of the sentence is lost. I would encourage the authors to use more succinct language to convey the specific point being made. This is particularly true in the discussion which needs substantial revision. These and other points are discussed below. 1) Section “PLM mechanosensory neurons displayed growth and guidance defects on loss of both citk1 and citk2” can be significantly shortened. Specifically, the discussion of the partially penetrant guidance/positioning phenotypes could be severely abbreviated or eliminated as no follow up mechanistic work was done. It distracts the reader from the main points of the paper if not better integrated. 2) Confirmation that W02B8.2 is the worm CITK homolog requires validation. Can the phenotype be suppressed by expression of the mammalian version of CITK or CITN? Both? 3) CIT-N (variant of CITK) has been implicated in Golgi positioning in hippocampal neurons - a dynein-dependent phenotype. Dynein has also been linked to microtubule polarity due to its role in microtubule sliding. Can you expound on the citk loss of function and include a discussion on how the phenotypes could be similar/different to the work on CIT-N in hippocampal neurons? Do dynein hypo- or hyper-morphs give you a similar defect in neuritis length and microtubule polarity? This point should be addressed either with further discussion or experiments as this phenotype has been clearly shown in post-mitotic neurons previously. 4) As you mention, CIT-K regulates actin dynamics in neurons. I think it is important to discern whether the effect you see is due to microtubules directly or through actin regulation. It would be useful to look at actin dynamics with live imaging or even actin structure to see if there is any reason to think the microtubule defects you see are secondary to actin disruption. Additionally, a more detailed assessment of the direct nature of the microtubule modifications is necessary in the discussion. This would be aided by a detailed assessment of the cellular localization of citk in these neurons. Does it localize to microtubule plus ends in neurites? 5) ASPM mutation gives the same phenotype as CITK but it is not delineated if this is because it is in parallel or the same cellular pathway. Is the CITK binding domain in ASPM known (or vice versa)? Could this be used in rescue analysis to further determine if these two are functioning together in neurite outgrowth? ASPM localizes to microtubule plus ends and recruits CITK during cell division. Is plus end localization of CITK lost in ASPM mutants or important for CITK function? Alternatively, do partial or full loss of ASPM and CITK together produce an additive phenotype? 6) The writing could be made a bit more straightforward. The long/wandering nature of the text makes it a bit difficult to follow. This is true in the discussion most clearly. For example, the paragraph that starts at line 555 is discussion the axon phenotype similarities to previous reports. Then branches into how citk may regulate actin for 1 sentence then astral microtubules in the next without linking these ideas at all. The following paragraph is 2 sentences, with the first one stretching 5 lines. It is unclear what is gained from this paragraph. 7) The discussion is a list of things that “should be tested” but weren’t in this study. Some things, particularly the actin cytoskeleton, should be addressed so more definitive conclusions can be drawn. The discussion makes it sound like this is just a replication of previous work without any progress. I don’t think this is the case. A stronger discussion of what has been learned/advanced is needed. Reviewer #3: In this manuscript, Sharma et al., studied the function of CITK proteins and ASPM-1 in regulating microtubule dynamics and polarity in C. elegans neurites. They took advantage of the genetic system and identified citk-1 mutations from a genetic screen that is designed to isolate MT regulators. Then they demonstrated that citk-1 and citk-2 functions redundantly in regulating MT dynamics and polarity in the PLM neurons. Because of previous literature linking these two proteins to ASPM1, they tested aspm1’s involvement and found that it also functions in PLM to regulate MTs. The experiments are well designed and executed. The findings are novel and interesting, but lack mechanisms. I support the publication of a revised manuscript. My main suggestions are two-fold: one is on writing and one is on the timing of the function of these proteins. Major points. 1. The introduction does not reflect an updated set of papers regarding MT organization in neurons. I would suggest the authors to systematically cite papers and separate them into the invertebrate and vertebrate systems because the MT polarity in neurites are somewhat different and the invertebrate systems often include in vivo analyses. 2. Despite of the very interesting observations on MT dynamics and polarity phenotypes, the mechanisms of these defects are unclear. I am not suggesting that the authors need to provide a thorough mechanism before this paper can be published. However, it might be very informative to know whether the function of citk and aspm1 are mitotic or postmitotic. In other words, are all the phenotypes caused by defects in early developmental stages (like during mitosis that generates PLM) or are these genes required for the maintenance of the MT dynamics and polarity. Since aspm1 is a temperature allele, that experiment can be easily performed. Are there ways to generate conditional alleles of citk-1 or -2 to test the requirement of these genes for the maintenance of MT properties? Minor points. 3. Line 60 “y-TURC” should be “g-TuRC”. 4. The Y-axis of figure 2D is not labeled. 5. In Figure 1, it seems strange to use mild and strong extension as a measure instead of directly measuring the length of the posterior process. 6. It will help to comment on the nature of the b- and a-tubulin mutations in the suppressors. The stop codon mutations are loss of function. Can the authors comment on why the loss of tubulin does not lead to growth defects in the anterior process. 7. Line 294, “… PLM neurons of citk mutant animals seemed to be significantly 295 higher than the number of plus-end-out comets implying a trend…” Change the statement to a more formal one. 8. Line414. “…Figure 4E-G)…” There is no 4G in the figure. ********** Have all data underlying the figures and results presented in the manuscript been provided? Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information., and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information., and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information., and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information. Reviewer #1: Yes Reviewer #2: None Reviewer #3: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy.... Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols Submitted filename: 2025_ PGENETICS-D-25-00512_Review.pdf 29 Jan 2026 Submitted filename: Response to reviewers 270126.docx 3 Mar 2026 PGENETICS-D-25-00512R1 Worm orthologues of cytokinesis-associated proteins CIT and ASPM regulate neuronal microtubule dynamics and polarity in C. elegans PLOS Genetics Dear Dr. Ghosh-Roy, Thank you for submitting your manuscript to PLOS Genetics. After careful consideration, we feel that it has merit but does not fully meet PLOS Genetics's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the minor points raised during the review process. Please submit your revised manuscript within by Apr 02 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Jeremy Nance Academic Editor PLOS Genetics Pablo Wappner Section Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics Reviewers' comments: Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: The authors have revised the manuscript by conducting new experiments to address some of the major issues that were brought up in the initial round of review. In particular, the genetic experiments provide support for the hypothesis that ASPM-1 and CITK-1/2 function in the same pathway; a model that was presented in the previous version but not examined experimentally. Moreover, clarification in the writing and the way figures are presented have made the manuscript easier to follow and more compelling. I do still have some minor suggested revisions outlined below, but otherwise feel that the work is acceptable for publication. a) Line 107: “in the microtubule dynamics may lead to distinct morphological changes…”. I suggest removing the word “may”. These phenotypes are well-established, and you show examples in this paper. So, we know for sure that disruption of MT dynamics cause morphological changes. b) Lines 132-133: “in-situ hybridization experiments, …, showed localization of CITK protein in a specific neuronal population in the cortex and thalamus …”. In situ experiments show mRNA localization, not protein. I would reword to say “showed CITK expression in a specific …”. c) Line 143: The sentence starting “Live imaging of EBP-2::GFP reporter …”. It is not clear here that the authors are starting to describe their own data. I would start this sentence instead saying “Here, using live imaging of an EBP-2::GFP reporter …”. Or maybe put a summarizing sentence before starting to describe the data. Something like “Here we show that the C. elegans orthologs of vertebrate of the CIT kinase, also regulate MT dynamics …”. This would make it clear that your shifting from background information to summarizing what you have discovered. d) Lines 400-402: The sentence “Notably, the fraction of minus-end-out microtubules in the posterior process increases significantly, mirroring the effects of citk-1 overexpression in wild-type animals (Fig S5J)” should be re-written so that the call to the supplemental figure is in the right location, and the authors should also call-out the data in wild-type. So, change to “Notably, the fraction of minus-end-out microtubules in the posterior process increases significantly (Fig S5J), mirroring the effects of citk-1 overexpression in wild-type animals (Fig 3D)” e) Line 408: “suggesting an epistatic genetic relationship”. I don’t think this is the correct term to use. Epistasis implies that the mutants have different phenotypes, and that in the double mutant one phenotype “covers-up” (epistasis literally means “stands upon”) the other. This is most evident when one mutation suppresses the phenotype of the other. What you are discovering here is that combining two mutations does not make the phenotype worse, so I would just say that the results are consistent with the genes functioning in the same pathway. f) Line 414: “equivalent to animals reared at the non-permissive temperature”. I find this confusing. if the mutation is embryonic lethal, how were the authors rearing the animals at the non-permissive temperature continuously? For the continuous non-permissive conditions, were eggs laid at the permissive temperature then shifted? They need to provide more details here, and in the Methods as to how these animals were maintained and when the temperature shifts were done in all their experiments with aspm-1(ts). The description in the methods (“grown at non-permissive temperature of 25°C according to the experimental paradigm”) is too vague. Reviewer #2: This revision has taken into account most of my concerns. I am still a bit worried about the strength of the assertion that these genes are the kinase-less orthologs of the mammalian gene without rescue showing functional redundancy. While cloning the gene may be difficult there are many mammalian orthologs already cloned by other groups. However, at this point, this concern can be remedied by tempering the language a bit. For example, on line 212, I would suggest changing the word "confirmed" which is very strong given the information presented to "suggests" or "argues" or "supports". Reviewer #4: The authors have addressed all of the major points raised by the reviewers, and I support publication. ********** Have all data underlying the figures and results presented in the manuscript been provided? Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information., and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information., and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information., and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information. Reviewer #1: Yes Reviewer #2: None Reviewer #4: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy.... Reviewer #1: No Reviewer #2: No Reviewer #4: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: Reproducibility: To enhance the reproducibility of your results, we recommend that authors deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols 19 Mar 2026 Submitted filename: Response to Reviewers.docx 26 Mar 2026 Dear Dr Ghosh-Roy, We are pleased to inform you that your manuscript entitled "Worm orthologues of cytokinesis-associated proteins CIT and ASPM regulate neuronal microtubule dynamics and polarity in C. elegans." has been editorially accepted for publication in PLOS Genetics. Congratulations! Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made. Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org. In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics! Yours sincerely, Jeremy Nance Academic Editor PLOS Genetics Pablo Wappner Section Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics www.plosgenetics.org BlueSky: @plos.bsky.social ---------------------------------------------------- Comments from the reviewers (if applicable): ---------------------------------------------------- Data Deposition If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our . As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our . As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our . As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.... The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-25-00512R2 More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support. Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present. requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present. requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present. requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present. ---------------------------------------------------- Press Queries If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.... PGENETICS-D-25-00512R2 Worm orthologues of cytokinesis-associated proteins CIT and ASPM regulate neuronal microtubule dynamics and polarity in C. elegans. Dear Dr Ghosh-Roy, We are pleased to inform you that your manuscript entitled "Worm orthologues of cytokinesis-associated proteins CIT and ASPM regulate neuronal microtubule dynamics and polarity in C. elegans." has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work! With kind regards, Anita Estes PLOS Genetics On behalf of: The PLOS Genetics Team Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom plosgenetics@plos.org | +44 (0) 1223-442823 plosgenetics.org | Twitter: @PLOSGenetics